2,6-Quinolinyl And 2,6-Naphthyl Derivatives, Processes For Preparing Them And Their Uses As Vla-4 Inhibitors

Information

  • Patent Application
  • 20080064720
  • Publication Number
    20080064720
  • Date Filed
    April 15, 2003
    22 years ago
  • Date Published
    March 13, 2008
    17 years ago
Abstract
The present invention concerns 2,6-quinolinyl and 2,6-naphthyl derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals for the treatment of VLA-4 dependent inflammatory diseases such as for example asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, psoriasis, urticaria, pruritus, eczema, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and atherosclerosis. Formula (I): wherein X is N or CH.
Description
EXAMPLE 1
Quinolinyl Derivatives: Racemic Synthesis
1.1 Synthesis of 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 38









1.1.1 Synthesis of methyl 2-amino-3-(4-nitrophenyl)propanoate 2

To a suspension of 4-nitrophenylalanine 1 (25 g) in methanol (10 ml/g) at 0° C. is added SOCl2 (2 equ.). After 30 minutes, the reaction is stirred at room temperature for 1 night. Volatiles are then evaporated and the residue is diluted in water. The solution is alkalinized with NaOH 2N and extracted with CH2Cl2. The organic phase is dried over MgSO4 and evaporated. No further purification is needed.


Yield: 79%.


MS (MH+): 225.


1.1.2 Synthesis of methyl 2-[(tert-butoxycarbonyl)amino]-3-(4-nitrophenyl)propanoate 3

Methyl 2-amino-3-(4-nitrophenyl)propanoate 2 (21 g) and powdered NaOH (1.2 equ.) are suspended in THF (5 ml/g). Boc2O (1.2 equ.) solubilized in THF (2 ml/g) is added slowly to the solution. The mixture is stirred for 1 h at room temperature, poured into water and then extracted with AcOEt (2×900 ml). The organic phase is dried over MgSO4 and evaporated to dryness. No further purification is needed.


Yield: 100%.


MS (MH+): 325.


1.1.3 Synthesis of methyl 3-(4-aminophenyl)-2-[(tert-butoxycarbonyl)amino]propanoate 4

To a solution of methyl 2-[(tert-butoxycarbonyl)amino]-3-(4 nitrophenyl)propanoate 3 (69.4 g) and NH4HCO2 (6.5 equ.) in CH3OH (20 ml/g) is added 5% Pd/C (15% in weight, 10 g). The temperature rises to 40° C. and then decreases. After stirring for 2 h at room temperature, the solution is filtered over celite and the solvent is evaporated. The residue is diluted in AcOEt and washed 3 times with water. The organic phase is dried over MgSO4 and evaporated to dryness. No further purification is needed.


Yield: 100%.


MS (MH+): 285.


1.1.4 Synthesis of methyl 2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-dichlorophenyl)-4-(phenylsulfanyl)-1,2,3,4-tetrahydro-6-quinolinyl]propanoate 5

Methyl 3-(4-aminophenyl)-2-[(tert-butoxycarbonyl)amino]propanoate 4 (38.2 g) solubilized in a 50/50 mixture of CH3CN/CH2Cl2 is added, at room temperature, to a mixture of Yb(OTf)3 (0.05 equ.) and MgSO4 (3 equ.) in CH3CN/CH2Cl2 (50/50,400 ml). Solid 2,6-dichlorobenzaldehyde (1.1 equ.) is then added and after 2 h, phenyl vinyl sulfide (1.2 equ.) is added dropwise. After one night, insolubles are filtered and the solvents evaporated. The residue is purified by silica gel chromatography using hexane mixture/AcOEt 80/20 as eluent to give methyl 2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-dichlorophenyl)-4-(phenylsulfanyl)-1,2,3,4-tetrahydro-6-quinolinyl]propanoate 5.


Yield: 81%.


MS (MH+): 587/589/591.


Methyl 2-[(tert-butoxycarbonyl)amino]-3-[2-phenyl-4-(phenylsulfanyl)-1,2,3,4-tetrahydro-6-quinolinyl]propanoate 5a and methyl 2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-dimethoxyphenyl)-4-(phenylsulfanyl)-1,2,3,4-tetrahydro-6-quinolinyl]propanoate 5b (MS (MH+): 579) can be synthesized according to the same method.


1.1.5 Synthesis of methyl 2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 6

Methyl 2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-dichlorophenyl)-4-(phenylsulfanyl)-1,2,3,4-tetrahydro-6-quinolinyl]propanoate 5 (32 g) is solubilized in dioxane (10 ml/g of 5). Water (0.5 ml/g of 5) and solid NaIO4 (1.1 equ.) are added, and the mixture is stirred at 80° C. for 40 h. The solvent is evaporated and the resulting mixture is extracted with CH2Cl2. The insoluble part is filtered and after evaporation, the residue is purified by silica gel chromatography using Hexane mixture/AcOEt 75/25 as eluent.


Yield: 88%.


MS (MH+): 475/477/479.


Methyl 2-[(tert-butoxycarbonyl)amino]-3-(2-phenyl-6-quinolinyl)propanoate 6a and methyl 2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-dimethoxyphenyl)-6-quinolinyl]propanoate 6b (MS (MH+): 467) can be synthesized according to the same method.


1.1.6 Synthesis of methyl 2-amino-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 33

9.15 g of methyl 2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 6 are solubilized in CH2Cl2 (50 ml). TFA (50 ml) is added at 0° C., and the mixture is stirred at RT for 6 h. After evaporation of the solvent, the residue is triturated in diethyl ether and cooled at 5° C. The solid product 33 is obtained by filtration.


Yield: 89%.


MS (MH+): 375/377/379.


1.1.7 Synthesis of methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 35

To 23.38 g of methyl 2-amino-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 33 (0.2 TFA salt) in CH2Cl2 (50 ml) are added, at 0° C., triethylamine (22 ml) and 2,6-dichlorobenzoyl chloride (6.22 ml) dissolved in CH2Cl2 (6 ml). The reaction is stirred at RT for 2 h. The organic phase is washed with water, dried over MgSO4 and evaporated under vacuum. The residue is purified by silica gel chromatography using CH2Cl2/Hexane 95/5 as eluent.


Yield: 96%.


MS (MH+): 547/549/551.


1.1.8 Synthesis of 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 38

Methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 35 (0.2 g) is solubilized in CH3CN/H2O/NaOH 0.1N (4 ml/0.22 ml/3.65 ml). After 1 night at room temperature, 10% KHSO4 (9 ml) is added and CH3CN is evaporated. The resulting aqueous phase is extracted two times with AcOEt (2×12 ml). The organic phase is washed with brine, dried over MgSO4 and evaporated under vacuum. The residue is purified by silica gel chromatography using CH2Cl2/CH3OH/NH4OH cc (90/10/1) as eluent.


Yield: 77%.


MS (MH+): 533/535/537.


1.2 Synthesis of methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 35 and methyl 2-[(2,6-dichlorobenzyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 41






1.2.1 Synthesis of methyl 2-[(2,6-dichlorobenzoyl)amino]-3-(4-nitrophenyl)propanoate 7

To a solution of methyl 2-amino-3-(4-nitrophenyl)propanoate 2 (9.5 g) in CH2Cl2 (40 ml) is added, at 0° C., 2,6-dichlorobenzoyl chloride (7.71 g) dissolved in CH2Cl2 (40 ml). DIPEA (2 equ.) is then added dropwise to the mixture at 0° C. The reaction is then risen at RT and pH is brought to 7-8 by addition of DIPEA. The mixture is stirred for 2 h, then evaporated and the residue is placed in AcOEt (175 ml). The organic phase is washed one time with 5% NaHCO3 (150 ml), one time with water, one time with 10% KHSO4 (150 ml) and one time with brine, dried over MgSO4 and evaporated. No further purification is needed.


Yield: 96%.


MS (MH+): 397/399/401.


1.2.2 Synthesis of methyl 2-[(2,6-dichlorobenzyl)amino]-3-(4-nitrophenyl)propanoate 7a

To a solution of methyl 2-amino-3-(4-nitrophenyl)propanoate 2 (6 g) in CH3CN (30 ml) is added, pulverized K2CO3 (11.095 g), 2,6-dichlorobenzyl bromide (6.42 g). The mixture is stirred at RT for 6 h then filtrated on decalite and evaporated. The residue is placed in CH2Cl2 (100 ml) and washed three time with water (100 ml) dried over MgSO4 and evaporated. The residue is purified by silica gel chromatography using AcOEt/hexane 10/90 as eluent.


Yield: 74%.


MS (MH+): 383/385/387.


1.2.3 Synthesis of methyl 3-(4-aminophenyl)-2-[(2,6-dichlorobenzoyl)amino]propanoate 8

Methyl 2-[(2,6-dichlorobenzoyl)amino]-3-(4-nitrophenyl)propanoate 7 (7 g) is solubilized in CH3OH in presence of Pt(S)/C (5% in weight). H2 pressure is then applied at RT for 2 h. The catalyst is filtered over celite and the solvent is evaporated to give methyl 3-(4-aminophenyl)-2-[(2,6-dichlorobenzoyl)amino]propanoate 8.


Yield: 100%.


MS (MH+): 367/369/371.


1.2.4 Synthesis of methyl 3-(4-aminophenyl)-2-[(2,6-dichlorobenzyl)amino]propanoate 8a

To methyl 2-[(2,6-dichlorobenzyl)amino]-3-(4-nitrophenyl)propanoate 7a (8.2 g) solubilized in CH3COOH in an ultrasonic bath is added PtO2 hydrate (typical Pt content 79-84%) (0.02 g). A H2 pressure of 15 psi is then applied at RT and consumed after 5 min. An other H2 pressure of 10 psis is then applied at RT and consumed after 5-10 min. A H2 pressure of 10 psis is again applied at RT and a stabilization is observed after 5 min. The catalyst is filtered over celite under nitrogen and washed with CH3COOH. The solvent is evaporated. AcOEt (200 ml) is added to the residue and this organic phase is washed three times with saturated NaHCO3 (200 ml), dried over MgSO4 and evaporated. The residue is purified by silica gel chromatography using CH2Cl2/CH3OH/NH4OH cc (99.75/0.25/0.025) as eluent.


Yield: 62%.


MS (MH+): 353/355/357.


1.2.5 Synthesis of methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-4-(phenylsulfanyl)-1,2,3,4-tetrahydro-6-quinolinyl]propanoate 9

Methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-4-(phenylsulfonyl)-1,2,3,4-tetrahydro-6-quinolinyl]propanoate 9 is prepared according to the method described for compound 5 in scheme 1.


Yield: 81%.


MS (MH+): 659/661.


Methyl 2-(benzoylamino)-3-[2-(2,6-dichlorophenyl)-4-(phenylsulfanyl)-1,2,3,4-tetrahydro-6-quinolinyl]propanoate 9a, methyl 2-[(2,6-dichlorobenzyl)amino]-3-[2-(2,6-dichlorophenyl)-4-(phenylsulfanyl)-1,2,3,4-tetrahydro-6-quinolinyl]propanoate 9b (MS (MH+): 645/647/649), methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dimethoxyphenyl)-4-(phenylsulfanyl)-1,2,3,4-tetrahydro-6-quinolinyl]propanoate 9c (MS (MH+): 651/653/655), methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[4-(phenylsulfanyl)-2-(1,3-thiazol-2-yl)-1,2,3,4-tetrahydro-6-quinolinyl]propanoate 9d (MS (MH+): 596/598/600), methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(3,5-dichloro-4-pyridinyl)-4-(phenylsulfanyl)-1,2,3,4-tetrahydro-6-quinolinyl]propanoate 9e (MS (MH+): 658/660/662) and methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[4-(phenylsulfanyl)-2-(4-pyridinyl)-1,2,3,4-tetrahydro-6-quinolinyl]propanoate 9f (MS (MH+): 590/592/594) can be synthesized according to the same method.


1.2.6 Synthesis of methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 35

Methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 35 is prepared according to the method described for compound 6 in scheme 1.


MS (MH+): 547/549/551.


Methyl 2-[(2,6-dichlorobenzyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 41 can be synthesized according to the same method.


MS (MH+): 533/535/537.


1.3 Synthesis of 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[({(2S)-1-[(4-methylphenyl)sulfonyl]piperidinyl}carbonyl)amino]propanoic acid 90
1.3.1 Synthesis of methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[(2S)-piperidinylcarbonyl]amino}propanoate 45

Tert-butyl (2S)-2-{[(1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-methoxy-2-oxoethyl)amino]carbonyl}-1-piperidinecarboxylate 42 is deprotected with TFA (see 1.1.6) to give methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[(2S)-piperidinylcarbonyl]amino}propanoate 45.


MS (MH+): 486/488/490.


1.3.2 Synthesis of methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[({(2S)-1-[(4-methylphenyl)sulfonyl]piperidinyl}carbonyl)amino]propanoate 46

To methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[(2S)-piperidinylcarbonyl]amino}propanoate 45 (0.2 TFA salt) (0.965 g) in CH2Cl2 (5 ml) are added, at 0 C, DIPEA (0.97 ml) and p-toluenesulfonyl chloride (0.282 g) dissolved in CH2Cl2. The reaction is stirred at RT for one night, then the mixture is diluted with CH2Cl2. The organic phase is washed 3 times with a brine solution, dried over MgSO4 and concentrated under vacuum. The residue is purified over silica gel using CH2Cl2/CH3OH (99.5/0.5) as eluent to give methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[({(2S)-1-[(4-methylphenyl)sulfonyl]piperidinyl}carbonyl)amino]propanoate 46.


Yield: 72%.


MS (MH+): 640/642/644.


1.3.3 Synthesis of 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[({(2S)-1-[(4-methylphenyl)sulfonyl]piperidinyl}carbonyl)amino]propanoic acid 90

To 455 mg of methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[({(2S)-1-[(4-methylphenyl)sulfonyl]piperidinyl}carbonyl)amino]propanoate 46 in CH3OH (5 ml) are added 0.8 ml of 1 N NaOH and 1 ml of water. The solution is stirred at RT overnight, and 1 N HCl (0.8 ml) is added to obtain a weakly acidic pH. Methanol is then evaporated, and the solid obtained is filtered, washed with water and dried to give 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[({(2S)-1-[(4-methylphenyl)sulfonyl]piperidinyl}carbonyl)amino]propanoic acid 90.


Yield: 82%.


MS (MH+): 626/628/630.


1.4 Synthesis of 2-{[(2,6-dichlorophenyl)(ethoxy)methylene]amino}-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 64

Compound 64 is synthesized according to Chem. Pharm. Bull. (1984). 32, (11), 4466-4477 starting from compound 35 followed by basic hydrolysis, as described for the transformation of compound 46 into compound 90.


MS (MH+): 561/563.


1.5 Synthesis of 2-[(2,6-dichlorobenzyl)(methyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 66






1.5.1 Synthesis of methyl 2-[(2,6-dichlorobenzyl)(methyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 51

To 100 mg of (methyl 2-[(2,6-dichlorobenzyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate) 41 in CH3OH (2.3 ml) are added, at 0° C., NaHCO3 (1 equ.) and CH3I (1 equ.). The reaction is stirred for 1 h at 0° C., and then at room temperature for 2 days. The solvent is evaporated and CH2Cl2 (10 ml) is added to the residue. The solution is washed with water, brine, again water and dried over MgSO4, filtered and evaporated. Due to an incomplete reaction, the protocol is repeated using a tenfold excess of NaHCO3 and CH3I in MeOH (5 ml). After a similar work-up, the residue is purified by silica gel chromatography using hexane/AcOEt 90/10 as eluent to give methyl 2-[(2,6-dichlorobenzyl)(methyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 51.


Yield: 43%.


MS (MH+): 547/549/551.


1.5.2 Synthesis of 2-[(2,6-dichlorobenzyl)(methyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 66

Hydrolysis of methyl 2-[(2,6-dichlorobenzyl)(methyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 51 is performed as described in 1.3.3 and gives 2-[(2,6-dichlorobenzyl)(methyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 66.


Yield: 65%.


MS (MH+): 533/535/537.


1.6 Synthesis of 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[(2-hydroxybenzoyl)amino]propanoic acid 71

Hydrolysis of methyl 2-{[2-(acetyloxy)benzoyl]amino}-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 70 as described in 1.3.3 gives 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[(2-hydroxybenzoyl)amino]propanoic acid 71.


Yield: 67%.


MS (MH+): 481/483/485.


1.7 Synthesis of 2-({[(2,6-dichlorophenyl)amino]carbonyl}amino)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 87
1.7.1 Synthesis of methyl 2-{[(2,6-dichloroanilino)carbonyl]amino}-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 52

To 0.62 g of methyl 2-amino-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 33 in CH2Cl2 (10 ml) are added 0.343 g of 2,6-dichlorophenyl isocyanate. The solution is stirred at RT and reduced to the half by evaporation. The solid residue is filtered and washed with CH2Cl2 and hexane to give a white powder that is recrystallised in hot CH3CN. The compound is purified over silica gel using CH2Cl2/CH3OH 99.5/0.5 as eluent. The obtained white powder is once more washed with CH3CN to give methyl 2-{[(2,6-dichloroanllino)carbonyl]amino}-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 52.


Yield: 36%.


MS (MH+): 562/564/566.


1.7.2 Synthesis of 2-({[(2,6-dichlorophenyl)amino]carbonyl}amino)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 87

Hydrolysis of methyl 2-{[(2,6-dichloroanilino)carbonyl]amino}-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 52 as described in 1.3.3 gives 2-({[(2,6-dichlorophenyl)amino]carbonyl}amino)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 87.


Yield: 58%.


MS (MH+): 548/550/552.


1.8 Synthesis of 2-[(2,6-dichlorobenzoyl)amino]-3-(2-phenoxy-6-quinolinyl)propanoic acid 81









1.8.1 Synthesis of 2-chloro-6-quinolinol 11

A solution of 2,6-quinolinediol 10 (5 g) in POCl3 (21 ml) and DMF (3.4 ml) is stirred for 12 h at room temperature, then heated for 1 h at 115° C. The reaction is poured into water (100 ml) at 0° C. and neutralized with a 32% aqueous NH3 solution. The solid obtained by filtration is washed with acetone, and the resulting organic phase is evaporated to give 2-chloro-6-quinolinol 11 as a solid. No further purification is needed.


Yield: 98%.


MS (MH+): 180.


1.8.2 Synthesis of 6-(benzyloxy)-2-chloroquinoline 12

To a solution of 2-chloro-6-quinolinol 11 (5.45 g) in DMF (100 ml) is added, at 0° C., cesium carbonate (11.9 g). After 15 minutes at 0° C., benzyl bromide (4 ml) is added and the reaction is stirred for 12 h at room temperature. Water (100 ml) is then added and the solid obtained is filtered and washed with pentane. No further purification is needed. 6-(benzyloxy)-2-chloroquinoline 12 is obtained as a powder.


Yield: 94%.


MS (MH+): 170.


1.8.3 Synthesis of 6-(benzyloxy)-2-phenoxyquinoline 13

To a 50% (w/w) NaOH solution (10.2 ml) is added phenol (0.697 g). After 50 minutes at room temperature, toluene (10.21 ml) and 6-(benzyloxy)-2-chloroquinoline 12 (2 g) and tetrabutyl ammonium (2.062 g) are added. The solution is stirred under argon at reflux for 24 h. Water (5 ml) is added and the solution is extracted with toluene (3×10 ml). The organic phases are dried over MgSO4 and evaporated under vacuum. The residue is purified by silica gel chromatography using AcOEt/cyclohexane 20/80 as eluent. The obtained solid is dissolved in AcOEt and pentane is added; 6-(benzyloxy)-2-phenoxyquinoline 13 precipitates as a white powder.


Yield: 70%.


MS (MH+): 328.


Compounds described in table 1 can be synthesized according to the same method.











TABLE 1





no
IUPAC Name
MS (MH+)







13a
6-(benzyloxy)-2-(4-chlorophenoxy)quinoline
362


13b
6-(benzyloxy)-2-methoxyquinoline
266


13c
6-(benzyloxy)-2-(2-methoxyphenoxy)quinoline
358


13d
6-(benzyloxy)-2-(2,6-dimethoxyphenoxy)quinoline
388


13e
6-(benzyloxy)-2-(2,6-dichlorophenoxy)quinoline
396/398









1.8.4 Synthesis of 2-phenoxy-6-quinolinol 14:


To a solution of 6-(benzyloxy)-2-phenoxyquinoline 13 (0.862 g) in CH3OH (10 ml) is added 10% of palladium on C (10%). The reaction is stirred under H2 at room temperature for 1 night. After filtration on celite and concentration, the residue is purified by silica gel chromatography using AcOEt/petroleum ether 10/90 as eluent to give compound 2-phenoxy-6-quinolinol 14 as an oil.


Yield: 61%.


MS (MH+): 238.


Compounds described in table 2 can be synthesized according to the same method.













TABLE 2







no
IUPAC Name
MS (MH+)









14a
2-(4-chlorophenoxy)-6-quinolinol
272



14b
2-methoxy-6-quinolinol
176



14c
2-(2-methoxyphenoxy)-6-quinolinol
268



14d
2-(2,6-dimethoxyphenoxy)-6-quinolinol
298



14e
2-(2,6-dichlorophenoxy)-6-quinolinol
306/308










1.8.5 Synthesis of 2-phenoxy-6-quinolinyl trifluoromethanesulfonate 15

To a solution of 2-phenoxy-6-quinolinol 14 (0.562 g) in CH2Cl2 (20 ml) is added pyridine (0.6 ml) under Argon. After 15 minutes at 0° C., trifluoromethanesulfonic anhydride (0.64 ml) is added. The reaction temperature is allowed to reach slowly room temperature. The reaction is stirred for 5 h and washed with a saturated solution of NaHCO3. The solution is extracted with CH2Cl2 (3×10 ml). The organic phase is dried over MgSO4 and evaporated under vacuum. The residue is purified by silica gel chromatography using AcOEt/petroleum ether 10/90 as eluent.


Yield: 87%.


MS (MH+): 370.


Compounds described in table 3 can be synthesized according to the same method.











TABLE 3





no
IUPAC Name
MS (MH+)







15a
2-(4-chlorophenoxy)-6-quinolinyl
404



trifluoromethanesulfonate


15b
2-methoxy-6-quinolinyl trifluoromethanesulfonate
308


15c
2-(2-methoxyphenoxy)-6-quinolinyl
400



trifluoromethanesulfonate


15d
2-(2,6-dimethoxyphenoxy)-6-quinolinyl
430



trifluoromethanesulfonate


15e
2-(2,6-dichlorophenoxy)-6-quinolinyl
438/440



trifluoromethanesulfonate









1.8.6 Synthesis of methyl-2-N-(tert-butoxycarbonyl)-acrylate 16

To a solution of methyl 2-[(tert-butoxycarbonyl)amino]-3-hydroxypropanoate (7.19 g) in CH2Cl2 (15 ml) are added 3.04 ml of mesyl chloride. NEt3 (13.64 ml) is then added at −50° C., under Argon. After 45 minutes at −50° C., the reaction warmed up to room temperature and stirred for 4 hours. The solution is poured into ice and the aqueous phase is extracted with CH2Cl2 (3×10 ml). The organic phases are dried over MgSO4 and evaporated to dryness. The residue is purified by silica gel chromatography using AcOEt/cyclohexane 20/80 as eluent to give 16 as oil.


Yield: 93%.


MS (MH+): 202.


1.8.7 Synthesis of methyl 2-[(tert-butoxycarbonyl)amino]-3-(2-phenoxy-6-quinolinyl)-2-propenoate 17

To a solution of 2-phenoxy-6-quinolinyl trifluoromethanesulfonate 15 (0.782 g) in DMF (20 ml) is added palladium acetate (0.0285 g). The solution is degassed with Argon for 30 minutes. Methyl-2-N-(tert-butoxycarbonyl)-acrylate 16 (1.065 g), tetrabutyl ammonium chloride (0.706 g) and NEt3 (0.342 ml) are then added. The solution is heated at 90° C. for 2 h and then poured in ice. The aqueous phase is extracted with AcOEt (3×15 ml). The organic phases are dried over MgSO4 and evaporated to dryness. The residue is purified by silica gel chromatography using AcOEt/ether petroleum 10/90 then 40/60 as eluent.


Yield: 91%.


MS (MH+): 421.


Compounds described in table 4 can be synthesized according to the same method.











TABLE 4





no
IUPAC Name
MS (MH+)







17a
methyl 2-[(tert-butoxycarbonyl)amino]-3-[2-(4-
455



chlorophenoxy)-6-quinolinyl]-2-propenoate


17b
methyl 2-[(tert-butoxycarbonyl)amino]-3-(2-methoxy-
359



6-quinolinyl)-2-propenoate


17c
methyl 2-[(tert-butoxycarbonyl)amino]-3-[2-(2-
451



methoxyphenoxy)-6-quinolinyl]-2-propenoate


17d
methyl 2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-
481



dimethoxyphenoxy)-6-quinolinyl]-2-propenoate


17e
methyl 2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-
490



dichlorophenoxy)-6-quinolinyl]-2-propenoate









1.8.8 Synthesis of methyl 2-[(tert-butoxycarbonyl)amino]-3-(2-phenoxy-6-quinolinyl) propanoate 18

To a solution of methyl 2-[(tert-butoxycarbonyl)amino]-3-(2-phenoxy-6-quinolinyl)-2-propenoate 17 (1.053 g) in methanol (15 ml) is added 10% of Pd over C (10%). The reaction is stirred at room temperature under H2 atmosphere overnight. After filtration over celite and concentration, the residue is purified by silica gel chromatography using AcOEt/ether petroleum 40/60 as eluent to give compound methyl 2-[(tert-butoxycarbonyl)amino]-3-(2-phenoxy-6-quinolinyl) propanoate 18 as an oil.


Yield: 82%.


MS (MH+): 423.


Compounds described in table 5 can be synthesized according to the same method.











TABLE 5





no
IUPAC Name
MS (MH+)







18a
methyl 2-[(tert-butoxycarbonyl)amino]-3-[2-(4-
457



chlorophenoxy)-6-quinolinyl]propanoate


18b
methyl 2-[(tert-butoxycarbonyl)amino]-3-(2-methoxy-
361



6-quinolinyl)propanoate


18c
methyl 2-[(tert-butoxycarbonyl)amino]-3-[2-(2-
453



methoxyphenoxy)-6-quinolinyl]propanoate


18d
methyl 2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-
483



dimethoxyphenoxy)-6-quinolinyl]propanoate


18e
methyl 2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-
491/493



dichlorophenoxy)-6-quinolinyl]propanoate









1.8.9 Synthesis of methyl 2-amino-3-(2-phenoxy-6-quinolinyl)propanoate 53

A solution of 0.737 g of methyl 2-[(tert-butoxycarbonyl)amino]-3-(2-phenoxy-6-quinolinyl) propanoate 18, trifluoroacetic acid (1 ml) and a drop of anisole in CH2Cl2 (6 ml) is stirred at 0° C. under argon. The reaction temperature is allowed to reach slowly room temperature, and the solution is stirred at this temperature for 2 h. After concentration, the residue is diluted in AcOEt (6 ml) and the mixture is neutralized with NaHCO3 (5%). The aqueous phase is extracted with AcOEt (4×5 ml). The organic phases are dried over MgSO4, filtered and concentrated. The obtained residue is purified over silica gel using (CH2Cl2/CH3OH 90/10+5% NEt3) as eluent to give methyl 2-amino-3-(2-phenoxy-6-quinolinyl)propanoate 53 as an oil.


Yield: 85%.


MS (MH+): 322.


1.8.10 Synthesis of methyl 2-[(2,6-dichlorobenzoyl)amino]-3-(2-phenoxy-6-quinolinyl) propanoate 54

To a solution of methyl 2-amino-3-(2-phenoxy-6-quinolinyl)propanoate 53 (0.363 g) in CH2Cl2 (5 ml) under argon is added NEt3 (0.937 ml). After 15 minutes, 2,6-dichlorophenylcarbonylchloride (0.241 ml) is added. The solution is stirred for 6 h at room temperature. After addition of NaHCO3 (5 ml), the aqueous phase is extracted with CH2Cl2 (3×10 ml). The organic phases are dried over MgSO4, filtered and concentrated. The obtained residue is purified over silica gel using AcOEt/petroleum ether 10/90 then 60/40 as eluent to give methyl 2-[(2,6-dichlorobenzoyl)amino]-3-(2-phenoxy-6-quinolinyl) propanoate 54.


Yield: 91%.


MS (MH+): 495.


1.8.11 Synthesis of 2-[(2,6-dichlorobenzoyl)amino]-3-(2-phenoxy-6-quinolinyl)propanoic acid 81

Methyl 2-[(2,6-dichlorobenzoyl)amino]-3-(2-phenoxy-6-quinolinyl) propanoate 54 is added to a mixture of CH3CN (10.99 ml), NaOH 1N (0.914 ml) and water (0.545 ml). The reaction is stirred at room temperature for 3 h. After addition of KHSO4 (10%, 22.4 ml), CH3CN is evaporated under vacuum. The aqueous phase is extracted with AcOEt (2×5 ml). The organic phases are washed with brine, dried over MgSO4 and evaporated under vacuum. The resulting residue is washed with 5 ml of pentane to give 2-[(2,6-dichlorobenzoyl)amino]-3-(2-phenoxy-6-quinolinyl)propanoic acid 81 as a white powder.


Yield: 82%.


MS (MH+): 481/483/485.


1.9 Synthesis of 2-[(2,6-dichlorobenzyl)oxy]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 91 and 2-[(2,6-dichlorobenzoyl)oxy]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 93









1.9.1 Synthesis of 6-(benzyloxy)-2-(2,6-dichlorophenyl)quinoline 19

To a solution of 3 g of 6-(benzyloxy)-2-chloroquinoline 12 in toluene (294 ml) is added Pd(PPh3)4 (1 g). After 30 minutes, a solution of 2,6-dichlorophenylboronic acid (4.22 g) in methanol (186 ml) and 120 ml of a saturated aqueous solution of NaHCO3 is added. The reaction is heated under reflux for 4 h. After evaporation, the aqueous phase is extracted with AcOEt (3×20 ml). The organic phases are washed with brine, dried over MgSO4 and evaporated to dryness. The residue is purified over silica gel using AcOEt/petroleum ether 5/95 then 10/90 as eluent to give 6-(benzyloxy)-2-(2,6-dichlorophenyl)quinoline 19 as an oil.


Yield: 62%.


MS (MH+): 380.


1.9.2 Synthesis of 2-(2,6-dichlorophenyl)-6-quinolinol 20

To a solution of 6-(benzyloxy)-2-(2,6-dichlorophenyl)quinoline 19 (2.5 g) in CH2Cl2 (20 ml) are added, at 0° C., 20 ml of BBr3 (1 M in CH2Cl2). The solution is stirred for 1 h at room temperature. Water (20 ml) is added and the resulting solution is alkalinized with 1 N NaOH. The aqueous phase is extracted with AcOEt (3×20 ml). The organic phases are washed with brine, dried over MgSO4 and evaporated. 2-(2,6-dichlorophenyl)-6-quinolinol 20 is obtained as a yellow solid and is used without further purification in the next step.


Yield: 100%.


MS (MH+): 290.


1.9.3 Synthesis of 2-(2,6-dichlorophenyl)-6-quinolinyl trifluoromethanesulfonate 21

To a solution of 2-(2,6-dichlorophenyl)-6-quinolinol 20 (1.9 g) in CH2Cl2 (20 ml) is added pyridine (1.6 ml) at room temperature. After 5 minutes, trifluoroacetic acid (1.7 ml) is added at 0° C. The solution is stirred for 2 h at 0° C. and a saturated solution of NaHCO3 (20 ml) is added. The aqueous phase is extracted with AcOEt (3×20 ml). The organic phases are washed with brine, dried over Na2SO4 and evaporated to dryness. The resulting solid 21 is used in the next step without further purification.


Yield: 100%.


MS (MH+): 422.


1.9.4 Synthesis of methyl 2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-propenoate 22

To a solution of 2-(2,6-dichlorophenyl)-6-quinolinyl trifluoromethanesulfonate 21 (0.67 g) in DMF (15 ml) are added 0.8 g of freshly prepared methyl-2-N-(tert-butoxycarbonyl)-acrylate 16, tetrabutylammonium (0.57 g) and NEt3 (0.3 ml). The solution is degassed for 20 minutes and Pd(OAc)2 (36 mg, 10% mol) is added. The solution is heated at 90° C. for 3 h, then water (10 ml) is added. The aqueous phase is extracted with AcOEt (3×10 ml), and the organic phases are washed with water (2×10 ml), brine and dried over MgSO4. After evaporation under vacuum, the residue is purified over silica gel using AcOEt/petroleum ether 20/80 as eluent.


Yield: 77%.


MS (MH+): 473.


1.9.5 Synthesis of methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxy-2-propenoate 23

To a solution of 2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-propenoate 22 (0.48 g) in CH2Cl2 (2 ml) are added at 0° C. two drops of anisole and 1.6 ml of trifluoroacetic acid. The solution is stirred for 2 h and a solution of NaHCO3 saturated is added to reach a basic pH. The aqueous phase is extracted with AcOEt (3×10 ml). The organic phases are washed with brine, dried over MgSO4 and concentrated. The residue is washed with methanol to give methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxy-2-propenoate 23.


Yield: 53%.


MS (MH+): 374.


1.9.6 Synthesis of methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxypropanoate 55

To a solution of methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxy-2-propenoate 23 (0.38 g) in CH3OH (2 ml) is added, at 0° C., NaBH4 (36 mg). The solution is stirred for 5 h. A saturated solution of NaHCO3 and then, a solution of 1 N NaOH are added until pH=11. The aqueous phase is extracted with AcOEt (3×10 ml). The organic phases are washed with brine, dried over MgSO4 and concentrated. The residue is purified over silica gel using AcOEt/petroleum ether 30/70 then 35/65 as eluent to give methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxypropanoate 55.


Yield: 65%.


MS (MH+): 377.


1.9.7 Synthesis of methyl 2-[(2,6-dichlorobenzyl)oxy]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 56

To a solution of methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxypropanoate 55 (0.159 g) and α-bromo-2,6-dichlorotoluene (1.05 g) in DMF (3.5 ml) is added 17 mg of NaH (60% dispersion in mineral oil) and Ag2O (0.102 g). The solution is stirred for 1 night at room temperature. A saturated solution of NaHCO3 is added. The aqueous phase is extracted with AcOEt (3×10 ml). The organic phases are washed with water (2×10 ml), with brine and dried over MgSO4. After concentration, the residue is purified twice over silica gel using AcOEt/petroleum ether 10/90 then 15/85 as eluent to give methyl 2-[(2,6-dichlorobenzyl)oxy]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 56.


Yield: 70%.


MS (MH+): 534.


1.9.8 Synthesis of 2-[(2,6-dichlorobenzyl)oxy]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 91

A solution of methyl 2-[(2,6-dichlorobenzyl)oxy]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 56 (0.123 g) and 1 N NaOH (0.236 ml) in a mixture of acetonitrile/water (3 ml/0.14 ml) is stirred for 3 h at room temperature. After addition of a 10% KHSO4 solution (3 ml), the mixture is concentrated. The aqueous phase is extracted with AcOEt (3×10 ml). The organic phases are washed with brine, dried over MgSO4 and evaporated under vacuum. The residue is washed with CH2Cl2 and 2-[(2,6-dichlorobenzyl)oxy]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 91 is obtained as a white powder.


Yield: 69%.


MS (MH+): 521.


1.9.9 Synthesis of 1-([2-(2,6-dichlorophenyl)-6-quinolinyl]methyl)-2-methoxy-2-oxoethyl 2,6-dichlorobenzoate 57

To a solution of methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxypropanoate 55 (0.104 g) in pyridine (1 ml) is added 2,6-dichlorobenzoyl chloride (0.2 ml). The solution is stirred for 6 h at room temperature. A saturated solution of NaHCO3 (10 ml) is added. The aqueous phase is extracted with AcOEt (3×10 ml). The organic phases are washed with brine, dried over MgSO4 and evaporated. The residue is purified twice over silica gel using AcOEt/petroleum ether (10/90 to 20/80) as eluent.


Yield: 88%.


MS (MH+): 550.


1.9.10 Synthesis of 2-[(2,6-dichlorobenzoyl)oxy]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 93

To a solution of 1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-methoxy-2-oxoethyl 2,6-dichlorobenzoate 57 (0.113 g) in 10 ml THF are added, at 0° C., 1 ml of LiOH (1 M) and 0.5 ml of H2O2 (30%). The solution is then stirred at room temperature for 18 h. After addition of 10 ml KHSO4 (10%), the THF is evaporated. The aqueous phase is extracted with AcOEt (3×10 ml). The organic phases are washed with brine, dried over MgSO4 and evaporated under vacuum. The residue is triturated in pentane to give 2[(2,6-dichlorobenzoyl)oxy]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 93 as a white powder.


Yield: 93%.


MS (MH+): 534.


1.10 Synthesis of 2,6-dichloro-N-[2-[2-(2,6-dichlorophenyl)-6-quinolinyl]-1-(1H-tetraazol-5-yl)ethyl]benzamide 126






1.10.1 Synthesis of N-(2-amino-1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-oxoethyl)-2,6-dichlorobenzamide 122.


2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 38 (2.12 g) in dry THF (15 ml) is cooled to −20° C. NEt3 (0.54 ml) and ethyl chloroformiate (0.37 ml) are added. The solution is stirred at this temperature for 20 minutes. The resulting solution is saturated with gaseous NH3 at −30° C. The mixture is allowed to reach room temperature. After one night, the residue is filtered and washed with THF, then dried under vacuum at 60° C. and purified over silica gel using CH2Cl2/CH3OH (95/5) as eluent to give N-(2-amino-1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-oxoethyl)-2,6-dichlorobenzamide 122.


Yield: 55%.


MS (MH+): 532/534/536.


1.10.2 Synthesis of 2,6-dichloro-N-{1-cyano-2-[2-(2,6-dichlorophenyl)-6-quinolinyl]ethyl}benzamide 58

To a solution of N-(2-amino-1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-oxoethyl)-2,6-dichlorobenzamide 122 (1.09 g) in pyridine (9 ml) is added p-toluenesulfonyl chloride (583 mg) at RT. The solution is stirred at 80° C. After one night, 120 mg of p-toluenesulfonyl chloride are added again to the mixture at RT to drive the reaction to completion. The solution is heated at 80° C. for one additional day. The organic phases are evaporated, AcOEt and a small amount of CH2Cl2 are added. The organic phases are washed 3 times with water, one time with a solution of NaHCO3, dried over MgSO4 and evaporated to dryness. The residue so obtained was purified over silica gel using CH2Cl2/CH3OH (99.25/0.75) as eluent to give 2,6-dichloro-N-{1-cyano-2-[2-(2,6-dichlorophenyl)-6-quinolinyl]ethyl}benzamide 58.


Yield: 65%.


MS (MH+): 514/516/518.


1.10.3 Synthesis of 2,6-dichloro-N-[2-[2-(2,6-dichlorophenyl)-6-quinolinyl]-1-(1H-tetraazol-5-yl)ethyl]benzamide 126

To 2,6-dichloro-N-{1-cyano-2-[2-(2,6-dichlorophenyl)-6-quinolinyl]ethyl}benzamide 58 (0.358 g) in toluene (5 ml) are added trimethylsilyl azide (184 μl) and dibutyltin oxide (17 mg). The solution is heated at reflux overnight, then evaporated under vacuum. The resulting residue is purified twice over silica gel using one time CH2Cl2/CH3OH 85/15 as eluent and the second time CH2Cl2/(CH3OH-10% NH4OH) 85/15 to give 2,6-dichloro-N-[2-[2-(2,6-dichlorophenyl)-6-quinolinyl]-1-(1H-tetraazol-5-yl)ethyl]benzamide 126.


Yield: 36%.


MS (MH+): 557/559/561.


1.11 Synthesis of 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[3,4-dioxo-2-(propylamino)-1-cyclobuten-1-yl]amino}propanoic acid 198






1.11.1 Synthesis of methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[(2-isopropoxy-3,4-dioxo-1-cyclobuten-1-yl)amino]propanoate 116

To a solution of methyl 2-amino-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 33 (2 TFA salt, 1.51 g) in CH3OH (15 ml) cooled with an ice bath, are added 0.96 ml of DIPEA and 495.6 mg of 3,4-diisopropoxy-3-cyclobutene-1,2-dione. The solution is stirred overnight at Rt. The solution is evaporated and the resulting residue is purified over silica gel using CH2Cl2/CH3OH (99.2/0.8) as eluent to give methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[(2-isopropoxy-3,4-dioxo-1-cyclobuten-1-yl)amino]propanoate 116.


Yield: 57%.


MS (MH+): 513/515/517.


1.11.2 Synthesis of methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[3,4-dioxo-2-(propylamino)-1-cyclobuten-1-yl]amino}propanoate 123

To methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[(2-isopropoxy-3,4-dioxo-1-cyclobuten-1-yl)amino]propanoate 116 (690 mg) in CH3OH (20 ml) are added 132 μl of n-propylamine. After addition of DMF (15 ml), the solution is stirred at RT overnight. The evaporation of CH3OH gives a DMF residue that is diluted in water (200 ml) and stirred overnight. The solid is filtered, washed with water then with MeOH, diluted in DMF, and n-propylamine (150 μl) is added to drive the reaction to completion. The solution is stirred at RT for 48 h, then poured into water. DMF is evaporated and the resulting solid is filtered, washed with water and dried. The product is purified by HPLC/MS (eluent: CH3CN/water/TFA, 8 minutes gradient from respectively 5/95/0.1 to 95/5/0.1). CH3CN is evaporated and water is added to the residue. The resulting solid is filtered and dried to give methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[3,4-dioxo-2-(propylamino)-1-cyclobuten-1-yl]amino}propanoate 123.


Yield: 10%.


MS (MH+): 513/515/517.


1.11.3 Synthesis of 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[3,4-dioxo-2-(propylamino)-1-cyclobuten-1-yl]amino}propanoic acid 198

The basic hydrolysis of methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-([3,4-dioxo-2-(propylamino)-1-cyclobuten-1-yl]amino)propanoate 123 into 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[3,4-dioxo-2-(propylamino)-1-cyclobuten-1-yl]amino}propanoic acid 198 follows the procedure described in 1.3.3.


Yield: 80%.


MS (MH+): 498/500/502.


1.12 Synthesis of 2,6-dichloro-N-(1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-{[2-(4-morpholinyl)ethyl]amino}-2-oxoethyl)benzamide 117






The transformation of 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 38 into 2,6-dichloro-N-(1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-{[2-(4-morpholinyl)ethyl]amino}-2-oxoethyl)benzamide 117 follows the same conditions that the transformation of compound 33 into compound 35 (scheme 1).


Yield: 48%.


MS (MH+): 645/647/649.


1.13 Synthesis of ({2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoyl}oxy)methyl pivalate 129






To 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 38 (534 mg) are added 195 μl of triethylamine and, after 15 minutes, 290 μl of chloromethyl pivalate. The solution is stirred at RT overnight and then poured in AcOEt. The organic phases are washed with water and brine, dried over MgSO4 and concentrated. The resulting residue is purified over silica gel using CH2Cl2/C2H5OH 99/1 as eluent to give ({2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoyl}oxy)methyl pivalate 129.


Yield: 85%.


MS (MH+): 647/649/651.


1.14. Synthesis of 2-{[(1-aminocyclopentyl)carbonyl]amino}-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 260






1.14.1. Synthesis of methyl 2-[({1-[(tert-butoxycarbonyl)amino]cyclopentyl}carbonyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 258.


Synthesis of methyl 2-[({1-[(tert-butoxycarbonyl)amino]cyclopentyl}carbonyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 258 from compound 33 follows the transformation of compound 33 into compound 35 as described in example 1.1.


Yield: 79%.


MS (MH+): 586/588/590.


1.14.2. Synthesis of methyl 2-{[(1-aminocyclopentyl)carbonyl]amino}-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 259

Synthesis of methyl 2-{[(1-aminocyclopentyl)carbonyl]amino}-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 259 from compound 258 follows the transformation of compound 6 into 33 as described is example 1.1.


Yield: 80%.


MS (MH+): 486/488/490.


1.14.3. Synthesis of 2-{[(1-aminocyclopentyl)carbonyl]amino}-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 260

Synthesis of 2-{[(1-aminocyclopentyl)carbonyl]amino}-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 260 from compound 259 follows the transformation of compound 35 into 38 as described is example 1.1.


Yield: 68%.


MS (MH+): 472/474/476.


1.15. Synthesis of tert-butyl 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 264.


Compound 264 is synthesized from compound 38 according to method described in Takeda K., Synthesis (1994), 1063.


Yield: 16%.


MS (MH+): 589/591/593/595/597.


EXAMPLE 2
Quinolinyl Derivatives: Stereospecific Synthesis
2.1 Synthesis of (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-({[(2S)-1-(methylsulfonyl)piperidinyl]carbonyl}amino)propanoic acid 125









2.1.1 Synthesis of tert-butyl (2S)-2-{[((1S)-1-([2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-methoxy-2-oxoethyl)amino]carbonyl)-1-piperidinecarboxylate 43

Synthesis of tert-butyl (2S)-2-{[((1S)-1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-methoxy-2-oxoethyl)amino]carbonyl}-1-piperidinecarboxylate 43 from compound 34 follows the transformation of compound 33 into compound 35 as described in scheme 1.


Yield: 71%.


MS (MH+): 586/588/590.


2.1.2 Synthesis of methyl (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[(2S)-piperidinylcarbonyl]amino}propanoate 44

The deprotection of tert-butyl (2S)-2-{[((1S)-1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-methoxy-2-oxoethyl)amino]carbonyl}-1-piperidinecarboxylate 43 is performed according to the procedure described in 1.1.6 and gives methyl (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[(2S)-piperidinylcarbonyl]amino}propanoate 44.


Yield: 100%.


MS (MH+): 486/488/490.


2.1.3 Synthesis of methyl (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-({[(2S)-1-(methylsulfonyl)piperidinyl]carbonyl}amino)propanoate 124

The mesylation of methyl (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[(2S)-piperidinylcarbonyl]amino}propanoate 44 is performed according to the procedure described in 1.3.2. using mesylchloride instead of p-toluenesulfonyl chloride and gives methyl (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-({[(2S)-1-(methylsulfonyl)piperidinyl]carbonyl}amino)propanoate 124.


Yield: 45%.


MS (MH+): 564/566/568.


2.1.4 Synthesis of (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-({[(2S)-1-(methylsulfonyl)piperidinyl]carbonyl}amino)propanoic acid 125

The basic hydrolysis of methyl (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-({[(2S)-1-(methylsulfonyl)piperidinyl]carbonyl}amino)propanoate 124 is performed according to the procedure described in 1.3.3.


Yield: 78%.


MS (MH+): 550/552/554.


2.2 Synthesis of (2R)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 40 and (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 39






2.2.1 Synthesis of methyl (2R)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 36 and methyl (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 37

Compounds 36 and 37 are obtained by chiral chromatography of racemic compound 35 (Chiralpak AD 100*500 nm, flow: 300 ml/min, length wave: 220 nm, Hexane mixture/ethanol 50/50 as eluent).


Compound 36: second eluted.


Compound 37: first eluted.


2.2.2 Synthesis of (2R)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 40 and (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 39

Hydrolysis at RT of methyl (2R)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 36 and methyl (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 37 (as described in example 1.1 for the synthesis of compound 38) gives respectively (2R)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 40 and (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 39.


2.3 Synthesis of (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 39 according to scheme 13






(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 39 can also be synthesised starting from (L)-p-nitro-Phe-OMe according to the synthesis described in scheme 2, involving methyl (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-4-(phenylsulfanyl)-1,2,3,4-tetrahydro-6-quinolinyl]propanoate 24 (MS (MH+): 659/661) as intermediate.


(2R)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 40 can be synthesised according to the same procedure but starting from (D)-p-nitro-Phe-OMe, involving methyl (2R)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-4-(phenylsulfanyl)-1,2,3,4-tetrahydro-6-quinolinyl]propanoate 24a (MS (MH+): 659/661) as intermediate.


2.4 Synthesis of (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 39 according to scheme 14.







(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 39 can also be synthesised starting from (L)-p-nitro-Phe-OMe according to the synthesis described in scheme 1, involving methyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-dichlorophenyl)-4-(phenylsulfanyl)-1,2,3,4-tetrahydro-6-quinolinyl]propanoate 25 (MS (MH+): 587/589/591), methyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 26 (MS (MH+): 475/477/479) and methyl (2S)-2-amino-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 34 (MS (MH+): 375/377/379) as intermediates.


Compounds described in table 6 can be synthesized as described for compound 25.











TABLE 6





no
IUPAC Name
MS (MH+)







25a
methyl (2R)-2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-
587/589/



dichlorophenyl)-4-(phenylsulfanyl)-1,2,3,4-tetrahydro-
591



6-quinolinyl]propanoate


25b
methyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-
579



dimethoxyphenyl)-4-(phenylsulfanyl)-1,2,3,4-



tetrahydro-6-quinolinyl]propanoate


25c
methyl (2R)-2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-
579



dimethoxyphenyl)-4-(phenylsulfanyl)-1,2,3,4-



tetrahydro-6-quinolinyl]propanoate


25d
methyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-
547



dimethylphenyl)-4-(phenylsulfanyl)-1,2,3,4-



tetrahydro-6-quinolinyl]propanoate


25e
methyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-[2-(3,5-
586/588/



dichloro-4-pyridinyl)-4-(phenylsulfanyl)-1,2,3,4-
590



tetrahydro-6-quinolinyl]propanoate










Compounds described in table 7 can be synthesized as described for compound 26.











TABLE 7





no
IUPAC Name
MS (MH+)







26a
methyl (2R)-2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-
475/477/



dichlorophenyl)-6-quinolinyl]propanoate
479


26b
methyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-
467



dimethoxyphenyl)-6-quinolinyl]propanoate


26c
methyl (2R)-2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-
467



dimethoxyphenyl)-6-quinolinyl]propanoate


26d
methyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-
435



dimethylphenyl)-6-quinolinyl]propanoate


26e
methyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-[2-(3,5-
476/478/



dichloro-4-pyridinyl)-6-quinolinyl]propanoate
480









(2R)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 40 can be synthesised according to the same procedure but starting from (D)-p-nitro-Phe-OMe, involving methyl (2R)-2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-dichlorophenyl)-4-(phenylsulfanyl)-1,2,3,4-tetrahydro-6-quinolinyl]propanoate 25a, methyl (2R)-2-[(tert-butoxycarbonyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 26a and methyl (2R)-2-amino-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 34a (MS (MH+): 375/377/379) as intermediates.


2.5 Synthesis of (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[({1-[2-(diethylamino)ethyl]cyclopentyl}carbonyl)amino]propanoic acid 272 according to the same method as described in 2.4 (scheme 14).

1-[2-(diethylamino)ethyl]cyclopentanecarboxylic acid 281 used for the synthesis of (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[({1-[2-(diethylamino)ethyl]cyclopentyl}carbonyl)amino]propanoic acid 272 is synthesised according to scheme 15.







2.5.1 Synthesis of methyl 1-[2-(diethylamino)ethyl]cyclopentanecarboxylate 280

To methyl cyclopentanecarboxylate (1 g) in THF (8 ml) at −61° C. is added a solution of 2M LDA (9.8 ml). The mixture is stirred at room temperature for 15 minutes, then 2-bromo-N,N-diethylethanamine hydrobromide (2.04 g) is added at −61° C. The mixture is stirred for 5 minutes at this temperature, then at room temperature. The solution became yellow and was diluted with water (30 ml). The organic phase is extracted twice with a brine solution (30 ml). The pH of the organic phase is adjusted to 4 with 6N HCl. After decantation, the aqueous phase is extracted with CH2Cl2 (20 ml) and the pH of aqueous phase adjusted to 12 with 6 N NaOH. After decantation, the organic phase is dried over MgSO4 and concentrated. The residue is treated with diethyl ether (10 ml) and the white solid is filtrated. Methyl 1-[2-(diethylamino)ethyl]cyclopentanecarboxylate 280 is obtained as a yellow liquid after concentration of the ether solution.


Yield: 79%.


MS (MH+): 228.


2.5.2 Synthesis of 1-[2-(diethylamino)ethyl]cyclopentanecarboxylic acid 281

Synthesis of 1-[2-(diethylamino)ethyl]cyclopentanecarboxylic acid 281 from 280 follows the transformation of compound 35 into 38 as described is example 1.1.


Yield: 94%.


MS (MH+): 214.


2.6 Synthesis of 2,6-dichloro-N-[(1R)-2-[2-(2,6-dichlorophenyl)-6-quinolinyl]-1-(hydroxymethyl)ethyl]benzamide 60 and 2,6-dichloro-N-[(1S)-2-[2-(2,6-dichlorophenyl)-6-quinolinyl]-1-(hydroxymethyl)ethyl]benzamide 59






2.6.1 Synthesis of 2,6-dichloro-N-[(1R)-2-[2-(2,6-dichlorophenyl)-6-quinolinyl]-1-(hydroxymethyl)ethyl]benzamide 60

To methyl (2R)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 36 (0,222 g) in THF (1 ml) is added, at 0° C., LiAlH4 (1,5 equ.). The solution is stirred at 0° C. for 1 hour. The reaction is quenched at −25° C. by successive additions of water (25 μl), 15% NaOH (25 μl) and water (75 μl). After evaporation of THF under vacuum, AcOEt is added. The organic phases are washed with water, brine, dried over MgSO4 and evaporated. The resulting residue is purified over silica gel using CH2Cl2/CH3OH/NH4OH (99/1/0,1) as eluent to give 2,6-dichloro-N-[(1R)-2-[2-(2,6-dichlorophenyl)-6-quinolinyl]-1-(hydroxymethyl)ethyl]benzamide 60.


Yield: 62%.


MS (MH+): 519/521/523.


2.6.2 Synthesis of 2,6-dichloro-N-[(1S)-2-[2-(2,6-dichlorophenyl)-6-quinolinyl]-1-(hydroxymethyl)ethyl]benzamide 59

The synthesis of 2,6-dichloro-N-[(1S)-2-[2-(2,6-dichlorophenyl)-6-quinolinyl]-1-(hydroxymethyl)ethyl]benzamide 59 follows the procedure described for compound 60 using methyl (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate 37 as starting material.


Yield: 48%.


MS (MH+): 519/521/523.


2.7 Synthesis of (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[4-(4-piperidinylmethyl)benzoyl]amino}propanoic acid 263






2.7.1 Synthesis of tert-butyl 4-(4-{[((15)-1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-methoxy-2-oxoethyl)amino]carbonyl}benzyl)-1-piperidinecarboxylate 261

Synthesis of tert-butyl 4-(4-{[((1S)-1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-methoxy-2-oxoethyl)amino]carbonyl}benzyl)-1-piperidinecarboxylate 261 follows the transformation of compound 33 into compound 258 as described is example 1.14.


Yield: 86%.


MS (MH+): 676/678/680.


2.7.2 Synthesis of methyl (2S-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[4-(4-piperidinylmethyl)benzoyl]amino}propanoate 262

Synthesis of methyl (2S-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[4-(4-piperidinylmethyl)benzoyl]amino}propanoate 262 follows the transformation of compound 258 into compound 259 as described is example 1.14.


Yield: 87%.


MS (MH+): 576/578/580.


2.7.3 Synthesis of (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[4-(4-piperidinylmethyl)benzoyl]amino}propanoic acid 263

Synthesis of (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[4-(4-piperidinylmethyl)benzoyl]amino}propanoic acid 263 follows the transformation of compound 259 into compound 260 as described is example 1.14.


Yield: 65%.


MS (MH+): 562/564/566.


EXAMPLE 3
Quinolinyl Derivatives: Combinatorial Chemistry









Wang Resin: p-Benzyloxybenzyl Alcohol resin: The polymer matrix is copolystyrene −1% DVB, 200-400 Mesh.


3.1 Synthesis of Compound 28

The resin (Fmoc (L)-Phe (4-NO2)-Wang Resin 200-400 Mesh (loading 0.75 mmol/g) is washed with MeOH, CH2Cl2 and DMF (3 times each, volume: 10 ml/g). The resin is prewashed with 20% piperidine in DMF (10 ml/g) for 5 minutes and then filtered. A 20% solution of piperidine in DMF (10 ml/g) is again added and stirring is maintained for 25 minutes. The resin is then filtered and washed 6 times with DMF and 3 times with CH2Cl2.


3.2 Synthesis of Compound 29
3.2.1 Using R8—COCl

The resin (compound 28) is washed 3 times with CH2Cl2 (volume: 10 ml/g). Ten equivalents of R8—COCl in CH2Cl2 (10 ml/g) are then added, followed by 10 equivalents of DIPEA. Stirring is maintained for 2 h. The resin is filtered and washed with CH2Cl2, DMF and MeOH (3 times each, volume: 10 ml/g). Completion of the reaction is checked using a chloranil test on a small resin sample.


3.2.2 Using R8—COOH.

The resin (compound 28) is washed with CH2Cl2 followed by DMF (3 times each, volume: 10 ml/g). 10 equivalents of TBTU and 10 equivalents of HOBT (both as solids) are then added to the resin followed by R8—COOH in DMF (10 ml/g). 30 equivalents of DIPEA are then added dropwise. Stirring is maintained for 2 h and the resin is filtered and washed 3 times with DMF, 3 times with CH2Cl2, 3 times with DMF and 3 times with MeOH (volume: 10 ml/g). Completion of the reaction is checked using a chloranil test on a small resin sample. If the reaction is not complete, the same procedure is started again but reaction is maintained overnight.


3.3 Synthesis of Compound 30

The resin (compound 29) is washed with CH2Cl2 followed by DMF (3 times each, volume: 10 ml/g). A 2M solution of 5 SnCl2.2H2O in DMF is then added (volume: 10 ml/g). Stirring is maintained 16 hours. The resin is then filtered and washed 6 times with DMF, 3 times with CH2Cl2, 3 times with CH2Cl2+10% TEA, 6 times with CH2Cl2 and 3 times with MeOH (volume: 10 ml/g).


3.4 Synthesis of Compound 31

The resin (compound 30) is washed 3 times with CH2Cl2 (volume: 10 ml/g). Ten equivalents of aldehyde R1CHO in CH2Cl2 (5 ml/g) are added to the resin and the slurry is stirred for 10 minutes. Yb(OTf)3 (0.05 equivalents, 5% mol) in CH3CN (10 ml/g) is added, then 10 equivalents of phenyl vinyl sulfide, and the stirring is maintained for 20 hours. The resin is filtered and washed with MeOH, CH2Cl2, DMF, CH2Cl2 and MeOH (3 times each, volume: 10 ml/g).


3.5 Synthesis of Compound 32

The resin (compound 31) is washed 3 times with CH2Cl2 (10 ml/g). 1.3 equivalents of mCPBA in CH2Cl2 (10 ml/g) are subsequently added. After 1 hour of stirring the resin is filtered and washed with CH2Cl2, DMF, CH2Cl2 and MeOH (3 times each, 10 ml/g). The resin in DMF (10 ml/g) is then heated at 80° C. for 16 hours. The resin is then washed with DMF, CH2Cl2 and MeOH (3 times each, 10 ml/g).


3.6 Synthesis of Compounds of Formula I

The resin (compound 32, 500 mg/well) is dried under vacuum and the compounds of formula I are cleaved from by treating the resin 3 times with 5 ml solution of TFA/Water 95/5 during 15 minutes. After filtration, the resin is washed with the same solvent. Solvent is removed at RT under vacuum using a Genevac apparatus and the product is purified by reverse phase chromatography (CH3CN/water/0.1% TFA).


Average overall yield: +/−30%.


EXAMPLE 4
Naphthyl Derivatives: Racemic Synthesis
4.1 Synthesis of 2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]propanoic acid 210









4.1.1 Synthesis of 6-bromo-2-naphthol 201

Deprotection of 2-bromo-6-methoxynaphthalene 200 as described in 1.9.2 gives 6-bromo-2-naphthol 201.


Yield: 94%.


MS (MH+): 227.


4.1.2 Synthesis of 2-(benzyloxy)-6-bromonaphthalene 202:


Protection of 6-bromo-2-naphthol 201 as described in 1.8.2 gives 2-(benzyloxy)-6-bromonaphthalene 202.


Yield: 98%.


MS (MH+): 313.


4.1.3 Synthesis of 2-(benzyloxy)-6-(2,6-dimethoxyphenyl)naphthalene 203

Reaction of 2-(benzyloxy)-6-bromonaphthalene 202 with 2,6-dimethoxyboronic acid as described in 1.9.1 gives 2-(benzyloxy)-6-(2,6-dimethoxyphenyl)naphthalene 203.


Yield: 95%.


MS (MH+): 370.


4.1.4 Synthesis of 6-(2,6-dimethoxyphenyl)-2-naphthol 204

Deprotection of 2-(benzyloxy)-6-(2,6-dimethoxyphenyl)naphthalene 203 as described in 1.8.4 gives 6-(2,6-dimethoxyphenyl)-2-naphthol 204.


Yield: 92%.


MS (MH+): 281.


4.1.5 Synthesis of 6-(2,6-dimethoxyphenyl)-2-naphthyl trifluoromethanesulfonate 205

Reaction of 6-(2,6-dimethoxyphenyl)-2-naphthol 204 with trifluoromethanesulfonic anhydride as described in 1.8.5 gives 6-(2,6-dimethoxyphenyl)-2-naphthyl trifluoromethanesulfonate 205.


Yield: 80%.


MS (MH+): 413.


4.1.6 Synthesis of methyl (2-(acetylamino)-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]-2-propenoate 206

Reaction of 6-(2,6-dimethoxyphenyl)-2-naphthyl trifluoromethanesulfonate 205 with methyl-2-N-acetyl-acrylate as described in 1.8.7 gives methyl (2-(acetylamino)-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]-2-propenoate 206.


Yield: 88%.


MS (MH+): 406.


4.1.7 Synthesis of methyl 2-(acetylamino)-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]propanoate 207

Hydrogenation of methyl (2-(acetylamino)-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]-2-propenoate 206 as described in 1.8.8. gives methyl 2-(acetylamino)-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]propanoate 207.


Yield: 99%.


MS (MH+): 408.


4.1.8 Synthesis of 2-amino-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]propanoic acid hydrochloride 208

To a solution of 1.4-dioxane (1 ml) are added successively 6 N HCl (3 ml) and methyl 2-(acetylamino)-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]propanoate 207 (0.135 g). The solution is stirred and heated at reflux for 4 hours, then cooled, and diethyl ether (5 ml) is added. The aqueous phase is extracted with diethyl ether (35 ml). The organic phase is concentrated under vacuum. The resulting residue is dried overnight under hight pression to give 2-amino-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]propanoic acid hydrochloride 208.


Yield: 81%.


MS (MH+): 352.


4.1.9 Synthesis of methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]propanoate 209

Esterification of 2-amino-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]propanoic acid hydrochloride 208 as described in 1.1.1 followed by acylation as described in 1.8.10 gives methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]propanoate 209.


Yield: 72%.


MS (MH+): 538/540/542.


4.1.10 Synthesis of 2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]propanoic acid 210

Hydrolysis of methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]propanoate 209 as described in 1.8.11 gives 2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]propanoic acid 210.


Yield: 64%.


MS (MH+): 524/526/528.


4.2 Synthesis of 2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dichlorophenyl)-2-naphthyl]propanoic acid 214









4.2.1 Synthesis of methyl 6-hydroxy-2-naphthoate 284

Reaction of 6-hydroxy-2-naphthoic acid 283 with SOCl2 as described in 1.1.1. gives methyl 6-hydroxy-2-naphthoate 284.


Yield: 97%.


MS (MH+): 202.


4.2.2 Synthesis of methyl 6-{[(trifluoromethyl)sulfonyl]oxy}-2-naphthoate 285

Reaction of methyl 6-hydroxy-2-naphthoate 284 with trifluoromethanesulfonic anhydride as described in 4.1.5. gives methyl 6-{[(trifluoromethyl)sulfonyl]oxy}-2-naphthoate 285.


Yield: 90%.


MS (MH+): 334.


4.2.3 Synthesis of methyl 6-(2,6-dichlorophenyl)-2-naphthoate 286

Reaction of methyl 6-{[(trifluoromethyl)sulfonyl]oxy}-2-naphthoate 285 as described in example 4.1.3. gives methyl 6-(2,6-dichlorophenyl)-2-naphthoate 286.


Yield: 93%.


MS (MH+): 331.


4.2.4 Synthesis of [6-(2,6-dichlorophenyl)-2-naphthyl]methanol 287:

Reaction of methyl 6-(2,6-dichlorophenyl)-2-naphthoate 286 as described in 2.5.1. gives [6-(2,6-dichlorophenyl)-2-naphthyl]methanol 287.


Yield: 98%.


MS (MH+): 303.


4.2.5 Synthesis of 2-(bromomethyl)-6-(2,6-dichlorophenyl)naphthalene 288

To a solution of PPh3 (0.251 g) in CH2Cl2 (1 ml) is added drop by drop, at 0° C., a solution of bromine (0.049 ml) in CH2Cl2 (1 ml). After 30 min, [6-(2,6-dichlorophenyl)-2-naphthyl]methanol 287 (0.242 g) is added. The mixture is stirred, under argon, at RT for 6 h. Water (2 ml) is added. The aqueous phase is extracted with CH2Cl2 (3×5 ml). The organic phases are dried over MgSO4 and evaporated under vacuum. The residue is purified by silica gel chromatography using AcOEt/cyclohexane 40/60 as eluent.


Yield: 95%.


MS (MH+): 366.


4.2.6 Synthesis of ethyl 2-(acetylamino)-3-[6-(2,6-dichlorophenyl)-2-naphthyl]propanoate 289

To a solution of Na (0.092 g) in ethanol (5 ml) is added diethyl 2-(acetylamino)malonate (0.870 g). The mixture is stirred for 1 h. A solution of 2-(bromomethyl)-6-(2,6-dichlorophenyl)naphthalene 288 (0.978 g) in ethanol (5 ml) is added, under argon. The mixture is stirred under reflux for 5 h. After addition of water (5 ml), the solution is concentrated under vacuum and then diluted with AcOEt (5 ml). The aqueous phase is extracted with AcOEt (3×15 ml). The organic phases are dried over MgSO4, filtrated and evaporated under vacuum. The residue is purified by silica gel chromatography using AcOEt/cyclohexane 20/80 then (40/60) as eluent.


Yield: 54%.


MS (MH+): 430.


4.2.7 Synthesis of 2-amino-3-[6-(2,6-dichlorophenyl)-2-naphthyl]propanoic acid hydrochloride 211

Reaction of ethyl 2-(acetylamino)-3-[6-(2,6-dichlorophenyl)-2-naphthyl]propanoate 289 with HCl as described in 4.1.8. gives 2-amino-3-[6-(2,6-dichlorophenyl)-2-naphthyl]propanoic acid hydrochloride 211.


Yield: 91%.


MS (MH+): 396.


4.2.8 Synthesis of 2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dichlorophenyl)-2-naphthyl]propanoic acid 214

2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dichlorophenyl)-2-naphthyl]propanoic acid 214 can be synthesised starting from 2-amino-3-[6-(2,6-dichlorophenyl)-2-naphthyl]propanoic acid hydrochloride 211 according to the synthesis described in scheme 19.


EXAMPLE 5
Naphthyl derivatives: stereospecific synthesis. Synthesis of (−)- and (+)-2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]propanoic acid 217 and 218






5.1 Synthesis of (−) and (+) methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]propanoate 215 and 216

Synthesis of (−) and (+) methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]propanoate 215 and 216 follows the transformation of compound 35 into 36 and 37 as described is example 2.2.


MS (MH+): 538/540/542.


5.2. Synthesis of (−) and (+) 2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]propanoic acid 217 and 218

According to the transformation of compounds 36 and 37 into 40 and 39 as described in example 2.2.


Yield: respectively 83% and 84%.


MS (MH+): 524/526/228.


Compounds described in table 8 can be synthesized according to one of these methods.


In the table, the stereochemical information is contained in the two columns headed ‘configuration data’. The second column indicates whether a compound is a pure configuration isomer or enantiomer (Pure), a racemate (Rac) or is a mixture of two or more stereoisomers, possibly in unequal proportions (Mixt). The first column contains the stereochemical assignment for each recognised center, following the IUPAC numbering used in the preceding column. A number alone indicates the existence of both configurations at that center. A number followed by ‘R’ or ‘S’ indicates the known absolute configuration at that center. A number followed by ‘§’ indicates the existence of only one but unknown absolute configuration at that center. The letter (A, B, C, D) in front is a way of distinguishing the various configuration isomers, enantiomers or racemates of the same structure.













TABLE 8








αD (25° C.)
LC-MS


no
Configuration data
IUPAC Name
or ee
(MH+)




















 33
2
Rac
methyl 2-amino-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate

375/377/379


 34
2S
Pure
methyl (2S)-2-amino-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate

375/377/379


 34a
2R
Pure
methyl (2R)-2-amino-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate

375/377/379


 35
2
Rac
methyl 2-{[(2,6-dichlorophenyl)carbonyl]amino}-3-[2-(2,6-

547/549/551





dichlorophenyl)-6-quinolinyl]propanoate


 36
2R
Pure
methyl (2R)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-
+52.77
547/549/551





quinolinyl]propanoate
(CH3CN, 1%)


 37
2S
Pure
methyl (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-
−51.95
547/549/551





quinolinyl]propanoate
(CH3CN, 1%)


 38
2
Rac
2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-

533/535/537





quinolinyl]propanoic acid


 39
2S
Pure
(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-
−61.92
533/535/537





quinolinyl]propanoic acid
(CH3OH, 1%)


 40
2R
Pure
(2R)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-
+57.25
533/535/537





quinolinyl]propanoic acid
(CH3OH, 1%)


 41
2
Rac
methyl 2-[(2,6-dichlorobenzyl)amino]-3-[2-(2,6-dichlorophenyl)-6-

533/535/537





quinolinyl]propanoate


 42
2S, 1
Mixt
tert-butyl (2S)-2{[(1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-

586/588/590





methoxy-2-oxoethyl)amino]carbonyl}-1-piperidinecarboxylate


 43
2S, 1S
Pure
tert-butyl (2S)-2-{[((1S)-1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-

586/588/590





2-methoxy-2-oxoethyl)amino]carbonyl}-1-piperidinecarboxylate


 44
2S, 2S
Pure
methyl (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[(2S)-

486/488/490





piperidinylcarbonyl]amino}propanoate


 45
2, 2S
Mixt
methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[(2S)-

486/488/490





piperidinylcarbonyl]amino}propanoate


 46
2, 2S
Mixt
methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[({(2S)-1-[(4-

640/642/644





methylphenyl)sulfonyl]piperidinyl}carbonyl)amino]propanoate


 47
2
Rac
methyl 2-({[1-(4-chlorophenyl)cyclopentyl]carbonyl}

581/583/585





amino)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate


 48
2S, 3aS, 7aS, 2
Mixt
tert-butyl (2S,3aS,7aS)-2-{[(1-{[2-(2,6-dichlorophenyl)-6-

626/628/630





quinolinyl]methyl}-2-methoxy-2-oxoethyl)amino]carbonyl}octahydro-1H-





indole-1-carboxylate


 49
2, 2S, 3aS, 7aS
Mixt
methyl 2-{[(2S,3aS,7aS)-octahydro-1H-indol-2-ylcarbonyl]amino}-3-[2-

526/528/530





(2,6-dichlorophenyl)-6-quinolinyl]propanoate


 50
2, 2S, 3aS, 7aS
Mixt
methyl 2-[({(2S,3aS,7aS)-1-[(4-methylphenyl)sulfonyl]octahydro-1H-

680/682/684





indol-2-yl}carbonyl)amino]-3-[2-(2,6-dichlorophenyl)-6-





quinolinyl]propanoate


 51
2
Rac
methyl 2-[(2,6-dichlorobenzyl)(methyl)amino]-3-[2-(2,6-dichlorophenyl)-

547/549/551





6-quinolinyl]propanoate


 52
2
Rac
methyl 2-{[(2,6-dichloroanilino)carbonyl]amino)-3-[2-(2,6-

562/564/566





dichlorophenyl)-6-quinolinyl]propanoate


 53
2
Rac
methyl 2-amino-3-[2-(phenyloxy)-6-quinolinyl]propanoate

322


 54
2
Rac
methyl 2-{[(2,6-dichlorophenyl)carbonyl]amino}-3-[2-(phenyloxy)-6-

495





quinolinyl]propanoate


 55
2
Rac
methyl 3-[2-(2,6-dimethylphenyl)-6-quinolinyl]-2-hydroxypropanoate

377


 56
2
Rac
methyl 2-{[(2,6-dichlorophenyl)methyl]oxy}-3-[2-(2,6-dichlorophenyl)-6-

534





quinolinyl]propanoate


 57
2
Rac
1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-(methyloxy)-2-

550





oxoethyl 2,6-dichlorobenzoate


 58
1
Rac
2,6-dichloro-N-{1-cyano-2-[2-(2,6-dichlorophenyl)-6-

514/516/518





quinolinyl]ethyl}benzamide


 59
1S
Pure
2,6-dichloro-N-[(1S)-2-[2-(2,6-dichlorophenyl)-6-quinolinyl]-1-
−36.25
519/521/523





(hydroxymethyl)ethyl]benzamide
(CH3OH, 1%)


 60
1R
Pure
2,6-dichloro-N-[(1R)-2-[2-(2,6-dichlorophenyl)-6-quinolinyl]-1-
+68.10
519/521/523





(hydroxymethyl)ethyl]benzamide
(CH3OH, 1%)


 61
2
Rac
2-(benzoylamino)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid

465/467/469


 62
2
Rac
2-[(2,6-dichlorobenzyl)amino]-3-[2-(2,6-dichlorophenyl)-6-

519/521/523





quinolinyl]propanoic acid


 63
2, 4R
Mixt
2-({[(4R)-3-acetyl-1,3-thiazolidin-4-yl]carbonyl}amino)-3-[2-(2,6-

518/520/522





dichlorophenyl)-6-quinolinyl]propanoic acid


 64
2
Rac
2-{[(2,6-dichlorophenyl)(ethoxy)methylene]amino}-3-[2-(2,6-

561/563





dichlorophenyl)-6-quinolinyl]propanoic acid


 65
2
Rac
2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dimethoxyphenyl)-6-

525/527/529





quinolinyl]propanoic acid


 66
2
Rac
2-[(2,6-dichlorobenzyl)(methyl)amino]-3-[2-(2,6-dichlorophenyl)-6-

533/535/537





quinolinyl]propanoic acid


 67
2
Rac
3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[(2,6-

525/527/529





dimethoxybenzoyl)amino]propanoic acid


 68
2
Rac
3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[(2,6-

493/495/497





dimethylbenzoyl)amino]propanoic acid


 69
2
Rac
2-{[(1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-methoxy-2-

613/615/617





oxoethyl)amino]carbonyl}benzyl benzoate


 70
2
Rac
methyl 2-{[2-(acetyloxy)benzoyl]amino}-3-[2-(2,6-dichlorophenyl)-6-

537/539/541





quinolinyl]propanoate


 71
2
Rac
3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[(2-

481/483/485





hydroxybenzoyl)amino]propanoic acid


 72
2
Rac
2-[(2,6-dichlorobenzoyl)amino]-3-(2-methoxy-6-quinolinyl)propanoic

419/421/423





acid


 73
2
Rac
2-(benzoylamino)-3-(2-phenyl-6-quinolinyl)propanoic acid

397


 74
2
Rac
2-[(2,6-dichlorobenzoyl)amino]-3-(2-phenyl-6-quinolinyl)propanoic acid

465/467/469


 75
2
Rac
methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(1,3-thiazol-2-yl)-6-

486/488/490





quinolinyl]propanoate


 76
2
Rac
2-[(2,6-dichlorobenzoyl)amino]-3-[2-(4-pyridinyl)-6-quinolinyl]propanoic

466/468/470





acid


 77
2
Rac
2-[(2,6-dichlorobenzoyl)amino]-3-[2-(1,3-thiazol-2-yl)-6-

472/474/476





quinolinyl]propanoic acid


 78
2
Rac
2-[(2,6-dichlorobenzoyl)amino]-3-[2-(3,5-dichloro-4-pyridinyl)-6-

534/536





quinolinyl]propanoic acid


 79
2
Rac
methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(3,5-dichloro-4-pyridinyl)-6-

548/550/552





quinolinyl]propanoate


 80
2
Rac
3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[(2,6-

501/503/505





difluorobenzoyl)amino]propanoic acid


 81
2
Rac
2-[(2,6-dichlorobenzoyl)amino]-3-(2-phenoxy-6-quinolinyl)propanoic

481/483/485





acid


 82
2S, 4R
Pure
methyl (2S)-2-({[(4R)-3-acetyl-1,3-thiazolidin-4-yl]carbonyl}amino)-3-[2-
−15.96
524





(2,6-dimethoxyphenyl)-6-quinolinyl]propanoate
(CH3OH, 1%)


 83
2S
Pure
methyl (2S)-2-{[2-chloro-4-(methylsulfonyl)benzoyl]amino}-3-[2-(2,6-
−57.25
591/593/595





dichlorophenyl)-6-quinolinyl]propanoate
(CH3CN, 1%)


 84
1R, 3S, 1
Mixt
(1R,3S)-3-{[(1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-methoxy-

557/559/561





2-oxoethyl)amino]carbonyl}-1,2,2-trimethylcyclopentanecarboxylic acid


 85
2S
Pure
(2S)-2-[(2-chloro-6-methylbenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-
−68.63
513/515/517





quinolinyl]propanoic acid
(CH3CN, 1%)


 86
2S
Pure
(2S)-2-{[2-chloro-4-(methylsulfonyl)benzoyl]amino}-3-[2-(2,6-
−50.32
577/579/581





dichlorophenyl)-6-quinolinyl]propanoic acid
(CH3CN, 1%)


 87
2
Rac
2-({[(2,6-dichlorophenyl)amino]carbonyl}amino)-3-[2-(2,6-

548/550/552





dichlorophenyl)-6-quinolinyl]propanoic acid


 88
2R (90%)
Mtxt
(2R)-2-({[1-(4-chlorophenyl)cyclopentyl]carbonyl}amino)-3-[2-(2,6-
ee: 82%
567/569/571



2S (10%)

dichlorophenyl)-6-quinolinyl]propanoic acid (90%)





(2S)-2-({[1-(4-chlorophenyl)cyclopentyl]carbonyl}amino)-3-[2-(2,6-





dichlorophenyl)-6-quinolinyl]propanoic acid (10%)


 89
2S
Pure
(2S)-2-({[1-(4-chlorophenyl)cyclopentyl]carbonyl}amino)-3-[2-(2,6-
ee: 98%
567/569/571





dichlorophenyl)-6-quinolinyl]propanoic acid


 90
2, 2S
Mixt
3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[({(2S)-1-[(4-

626/628/630





methylphenyl)sulfonyl]piperidinyl}carbonyl)amino]propanoic acid


 91
2
Rac
2-[(2,6-dichlorobenzyl)oxy]-3-[2-(2,6-dichlorophenyl)-6-

521





quinolinyl]propanoic acid


 92
1R, 3S, 1
Mixt
(1R,3S)-3-[({1-carboxy-2-[2-(2,6-dichlorophenyl)-6-

543/545/547





quinolinyl]ethyl}amino)carbonyl]-1,2,2-trimethylcyclopentanecarboxylic





acid


 93
2
Rac
2-[(2,6-dichlorobenzoyl)oxy]-3-[2-(2,6-dichlorophenyl)-6-

534





quinolinyl]propanoic acid


 94
2S
Pure
(2S)-2-[(2,6-difluorobenzoyl)amino]-3-[2-(2-nitrophenyl)-6-
ee: >95%
478





quinolinyl]propanoic acid


 95
2S
Pure
(2S)-2-[(2,6-difluorobenzoyl)amino]-3-{2-[2-(trifluoromethyl)phenyl]-6-
ee: >95%
501





quinolinyl}propanoic acid


 96
2S
Pure
(2S)-3-[2-(2-chloro-6-fluorophenyl)-6-quinolinyl]-2-[(2,6-
ee: >95%
485





difluorobenzoyl)amino]propanoic acid


 97
2S
Pure
(2S)-2-[(2,6-difluorobenzoyl)amino]-3-[2-(2-methoxy-1-naphthyl)-6-
ee: >95%
513





quinolinyl]propanoic acid


 98
2S
Pure
(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2-nitrophenyl)-6-
ee: >95%
510





quinolinyl]propanoic acid


 99
2S
Pure
(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-{2-[2-(trifluoromethyl)phenyl]-6-
ee: >95%
533





quinolinyl}propanoic acid


100
2S
Pure
(2S)-3-[2-(2-chloro-6-fluorophenyl)-6-quinolinyl]-2-[(2,6-
ee: >95%
517





dichlorobenzoyl)amino]propanoic acid


101
2S
Pure
(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2-methoxy-1-naphthyl)-6-
ee: >95%
545





quinolinyl]propanoic acid


102
2S
Pure
(2S)-2-[(2-chloro-6-methylbenzoyl)amino]-3-[2-(2-nitrophenyl)-6-
ee: >95%
490





quinolinyl]propanoic acid


103
2S
Pure
(2S)-2-[(2-chloro-6-methylbenzoyl)amino]-3-{2-[2-
ee: >95%
513





(trifluoromethyl)phenyl]-6-quinolinyl}propanoic acid


104
2S
Pure
(2S)-3-[2-(2-chloro-6-fluorophenyl)-6-quinolinyl]-2-[(2-chloro-6-
ee: >95%
497





methylbenzoyl)amino]propanoic acid


105
2S
Pure
(2S)-2-[(2-chloro-6-methylbenzoyl)amino]-3-[2-(2-methoxy-1-naphthyl)-
ee: >95%
525





6-quinolinyl]propanoic acid


106
2S
Pure
(2S)-2-{[2-chloro-4-(methylsulfonyl)benzoyl]amino}-3-{2-[2-nitrophenyl]-
ee: >95%
554





6-quinolinyl}propanoic acid


107
2S
Pure
(2S)-2-{[2-chloro-4-(methylsulfonyl)benzoyl]amino}-3-{2-[2-
ee: >95%
577





(trifluoromethyl)phenyl]-6-quinolinyl}propanoic acid


108
2S
Pure
(2S)-3-[2-(2-chloro-6-fluorophenyl)-6-quinolinyl]-2-{[2-chloro-4-
ee: >95%
561





(methylsulfonyl)benzoyl]amino}propanoic acid


109
2S
Pure
(2S)-2-{[2-chloro-4-(methylsulfonyl)benzoyl]amino}-3-[2-(2-methoxy-1-
ee: >95%
589





naphthyl)-6-quinolinyl]propanoic acid


110
2S, 4R
Pure
(2S)-2-({[(4R)-3-acetyl-1,3-thiazolidin-4-yl]carbonyl}amino)-3-[2-(2,6-
ee: >98%
510





dimethoxyphenyl)-6-quinolinyl]propanoic acid


111
2, 2S, 3aS, 7aS
Mixt
2-[({(2S,3aS,7aS)-1-[(4-methylphenyl)sulfonyl]octahydro-1H-indol-2-

666/668/670





yl}carbonyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic





acid


112
2S, 2S
Pure
methyl (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-({[(2S)-2-
 −3.54
487/489/491





methyltetrahydro-2-furanyl]carbonyl}amino)propanoate
(DMSO, 1%)


113
2S, 2R
Pure
methyl (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-({[(2R)-2-
−13.7 
487/489/491





methyltetrahydro-2-furanyl]carbonyl}amino)propanoate
(DMSO, 1%)


114
2S, 2S
Pure
(2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-({[(2S)-2-
+13.54
473/475/477





methyltetrahydro-2-furanyl]carbonyl}amino)propanoic acid
(DMSO, 1%)


115
2S, 2R
Pure
(2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-({[(2R)-2-
 +5.77
473/475/477





methyltetrahydro-2-furanyl]carbonyl}amino)propanoic acid
(DMSO, 1%)


116
2
Rac
methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[(2-isopropoxy-3,4-

513/515/517





dioxo-1-cyclobuten-1-yl)amino]propanoate


117
1
Rac
2,6-dichloro-N-(1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-{[2-(4-

645/647/649





morpholinyl)ethyl]amino}-2-oxoethyl)benzamide


118
1
Rac
2,6-dichloro-N-(1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-oxo-2-

629/631/633





{[2-(1-pyrrolidinyl)ethyl]amino}ethyl)benzamide


119
1
Rac
2,6-dichloro-N-(1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-{[2-

603/605/607





(dimethylamino)ethyl]amino}-2-oxoethyl)benzamide


120
1
Rac
2,6-dichloro-N-[1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-

546/548/550





(methylamino)-2-oxoethyl]benzamide


121
1
Rac
2,6-dichloro-N-[1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-

548/550/552





(hydroxyamino)-2-oxoethyl]benzamide


122
1
Rac
N-(2-amino-1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-oxoethyl)-

532/534/536





2,6-dichlorobenzamide


123
2
Rac
methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[3,4-dioxo-2-

513/515/517





(propylamino)-1-cyclobuten-1-yl]amino}propanoate


124
2S, 2S
Pure
methyl (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-({[(2S)-1-
 −1.55
564/566/568





(methylsulfonyl)piperidinyl]carbonyl}amino)propanoate
(CH2Cl2, 1%)


125
2S, 2S
Pure
(2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-({[(2S)-1-
+29.41
550/552/554





(methylsulfonyl)piperidinyl]carbonyl}amino)propanoic acid
(CH2Cl2, 1%)


126
1
Rac
2,6-dichloro-N-[2-[2-(2,6-dichlorophenyl)-6-quinolinyl]-1-(1H-tetraazol-

557/559/561





5-yl)ethyl]benzamide


127
2
Rac
methyl 2-{[(6-amino-3-pyridinyl)carbonyl]amino}-3-[2-(2,6-

495/497/499





dichlorophenyl)-6-quinolinyl]propanoate


128
2
Rac
methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2-methoxyphenoxy)-6-

525





quinolinyl]propanoate


129
2
Rac
({2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-

647/649/651





quinolinyl]propanoyl}oxy)methyl pivalate


130
2S, 4R
Pure
methyl (2S)-2-({[(4R)-3-acetyl-1,1-dioxido-1,3-thiazolidin-4-
+10.51
564/566/568





yl]carbonyl}amino)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate
(CH3OH, 1%)


131
**

2-[({(2S,3aS,7aS)-1-[(4-methylphenyl)sulfonyl]octahydro-1H-indol-2-

632





yl}carbonyl)amino]-3-[2-(2-chlorophenyl)-6-quinolinyl]propanoic acid


132
**

3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[(2,6-

458





dichlorophenyl)sulfonyl]amino}propanoic acid


133
**

3-[2-(3,4-dichlorophenyl)-6-quinolinyl]-2-{[(2,6-

569





dichlorophenyl)sulfonyl]amino}propanoic acid


134
**

3-[2-(2-bromophenyl)-6-quinolinyl]-2-[(2,6-

543





dichlorobenzoyl)amino]propanoic acid


135
**

3-[2-(2-bromophenyl)-6-quinolinyl]-2-[({(2S)-1-[(4-

636





methylphenyl)sulfonyl]piperidinyl}carbonyl)amino]propanoic acid


136
**

2-[({(2S,3aS,7aS)-1-[(4-methylphenyl)sulfonyl]octahydro-1H-indol-2-

676





yl}carbonyl)amino]-3-[2-(2-bromophenyl)-6-quinolinyl]propanoic acid


137
**

3-{2-[2-chloro-5-(trifluoromethyl)phenyl]-6-quinolinyl}-2-[(2,6-

567





dichlorobenzyl)amino]propanoic acid


138
**

2-[(2-chloro-6-methylbenzoyl)amino]-3-{2-[2-chloro-5-

547





(trifluoromethyl)phenyl]-6-quinolinyl}propanoic acid


139
**

2-{[2-chloro-4-(methylsulfonyl)benzoyl]amino}-3-{2-[2-chloro-5-

611





(trifluoromethyl)phenyl]-6-quinolinyl}propanoic acid


140
**

3-{2-[2-chloro-5-(trifluoromethyl)phenyl]-6-quinolinyl}-2-[({(2S)-1-[(4-

660





methylphenyl)sulfonyl]piperidinyl}carbonyl)amino]propanoic acid


141
**

2-[({(2S,3aS,7aS)-1-[(4-methylphenyl)sulfonyl]octahydro-1H-indol-2-

700





yl}carbonyl)amino]-3-{2-[2-chloro-5-(trifluoromethyl)phenyl]-6-





quinolinyl}propanoic acid


142
**

3-(2-cyclohexyl-6-quinolinyl)-2-[(2,6-dichlorobenzoyl)amino]propanoic

471





acid


143
**

2-({[1-(4-chlorophenyl)cyclopentyl]carbonyl}amino)-3-(2-cyclohexyl-6-

505





quinolinyl)propanoic acid


144
**

2-({[1-(4-chlorophenyl)cyclopentyl]carbonyl}amino)-3-[2-(2-nitrophenyl)-

544





6-quinolinyl]propanoic acid


145
**

3-(2-cyclohexyl-6-quinolinyl)-2-[(2,6-

463





dimethoxybenzoyl)amino]propanoic acid


146
**

2-[(2,6-dimethoxybenzoyl)amino]-3-[2-(2-nitrophenyl)-6-

502





quinolinyl]propanoic acid


147
**

2-[(2-chloro-6-methylbenzoyl)amino]-3-(2-cyclohexyl-6-

451





quinolinyl)propanoic acid


148
**

3-{2-[2-(1,3-benzodioxol-5-yl)-1-methylethyl]-6-quinolinyl}-2-[(2-chloro-

531





6-methylbenzoyl)amino]propanoic acid


149
**

3-(2-bicyclo[2.2.1]hept-5-en-2-yl-6-quinolinyl)-2-{[2-chloro-4-

525





(methylsulfonyl)benzoyl]amino}propanoic acid


150
**

2-{[2-chloro-4-(methylsulfonyl)benzoyl]amino}-3-[2-(1-phenylethyl)-6-

537





quinolinyl]propanoic acid


151
**

3-{2-[2-(1,3-benzodioxol-5-yl)-1-methylethyl]-6-quinolinyl}-2-{[2-chloro-

595





4-(methylsulfonyl)benzoyl]amino}propanoic acid


152
**

2-({[1-(4-chlorophenyl)cyclopentyl]carbonyl}amino)-3-[2-(2-

529





methoxyphenyl)-6-quinolinyl]propanoic acid


153
**

2-({[1-(4-chlorophenyl)cyclopentyl]carbonyl}amino)-3-[2-(2-6-

559





dimethoxyphenyl)-6-quinolinyl]propanoic acid


154
**

2-[(2,6-difluorobenzoyl)amino]-3-[2-(2,6-dimethoxyphenyl)-6-

493





quinolinyl]propanoic acid


155
**

2-[(2-chloro-6-methylbenzoyl)amino]-3-[2-(2-methoxyphenyl)-6-

475





quinolinyl]propanoic acid


156
**

2-[(2-chloro-6-methylbenzoyl)amino]-3-[2-(2,3-dimethoxyphenyl)-6-

505





quinolinyl]propanoic acid


157
**

2-{[2-chloro-4-(methylsulfonyl)benzoyl]amino}-3-[2-(2-methoxyphenyl)-

539





6-quinolinyl]propanoic acid


158
**

2-{[2-chloro-4-(methylsulfonyl)benzoyl]amino}-3-[2-(2,3-

569





dimethoxyphenyl)-6-quinolinyl]propanoic acid


159
**

2-{[2-chloro-4-(methylsulfonyl)benzoyl]amino}-3-[2-(2,6-

569





dimethoxyphenyl)-6-quinolinyl]propanoic acid


160
**

2-{[(1-acetyl-2-pyrrolidinyl)carbonyl]amino}-3-[2-(2,6-dimethoxyphenyl)-

492





6-quinolinyl]propanoic acid


161
**

2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,4-dichlorophenyl)-6-

533





quinolinyl]propanoic acid


162
**

2-[(2,6-dichlorobenzoyl)amino]-3-{2-[4-(methylsulfonyl)phenyl]-6-

543





quinolinyl}propanoic acid


163
**

3-[2-(2-chloro-6-fluorophenyl)-6-quinolinyl]-2-({[1-(4-

551





chlorophenyl)cyclopentyl]carbonyl}amino)propanoic acid


164
**

2-({[1-(4-chlorophenyl)cyclopentyl]carbonyl}amino)-3-{2-[2-

567





(trifluoromethyl)phenyl]-6-quinolinyl}propanoic acid


165
**

2-({[1-(4-chlorophenyl)cyclopentyl]carbonyl}amino)-3-{2-[4-

577





(methylsulfonyl)phenyl]-6-quinolinyl}propanoic acid


166
**

3-[2-(2,4-dichlorophenyl)-6-quinolinyl]-2-[(2,6-

525





dimethoxybenzoyl)amino]propanoic acid


167
**

3-[2-(2-chloro-6-fluorophenyl)-6-quinolinyl]-2-[(2,6-

509





dimethoxybenzoyl)amino]propanoic acid


168
**

2-[(2,6-dimethoxybenzoyl)amino]-3-{2-[2-(trifluoromethyl)phenyl]-6-

525





quinolinyl}propanoic acid


169
**

2-[(2,6-difluorobenzoyl)amino]-3-{2-[4-(methylsulfonyl)phenyl]-6-

511





quinolinyl}propanoic acid


170
**

2-[(2-chloro-6-methylbenzoyl)amino]-3-(2-mesityl-6-

487





quinolinyl)propanoic acid


171
**

2-[(2-chloro-6-methylbenzoyl)amino]-3-[2-(2,4-dichlorophenyl)-6-

513





quinolinyl]propanoic acid


172
**

2-{[2-chloro-4-(methylsulfonyl)benzoyl]amino}-3-(2-mesityl-6-

551





quinolinyl)propanoic acid


173
**

2-{[2-chloro-4-(methylsulfonyl)benzoyl]amino}-3-[2-(2,4-

577





dichlorophenyl)-6-quinolinyl]propanoic acid


174
**

2-{[(1-acetyl-2-pyrrolidinyl)carbonyl]amino}-3-[2-(2,4-dichlorophenyl)-6-

500





quinolinyl]propanoic acid


175
**

2-{[(1-acetyl-2-pyrrolidinyl)carbonyl]amino}-3-[2-(2-chloro-6-

484





fluorophenyl)-6-quinolinyl]propanoic acid


176
**

3-{2-[5-chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-6-

571





quinolinyl}-2-[(2,6-dichlorobenzoyl)amino]propanoic acid


177
2S
Pure
(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dimethylphenyl)-6-

493





quinolinyl]propanoic acid


178
**

2-({[1-(4-chlorophenyl)cyclopentyl]carbonyl}amino)-3-[2-(2,3-

605





difluorophenyl)-6-quinolinyl]propanoic acid


179
**

2-({[1-(4-chlorophenyl)cyclopentyl]carbonyl}amino)-3-[2-(2-methoxy-1-

579





naphthyl)-6-quinolinyl]propanoic acid


180
**

2-({[1-(4-chlorophenyl)cyclopentyl]carbonyl}amino)-3-[2-(2,6-

527





dimethylphenyl)-6-quinolinyl]propanoic acid


181
**

2-[(2,6-dimethoxybenzoyl)amino]-3-[2-(2-methoxy-1-naphthyl)-6-

537





quinolinyl]propanoic acid


182
**

2-[(2-chloro-6-methylbenzoyl)amino]-3-{2-[5-chloro-1-methyl-3-

551





(trifluoromethyl)-1H-pyrazol-4-yl]-6-quinolinyl}propanoic acid


183
**

2-[(2-chloro-6-methylbenzoyl)amino]-3-[2-(2,6-dimethylphenyl)-6-

473





quinolinyl]propanoic acid


184
**

2-{[2-chloro-4-(methylsulfonyl)benzoyl]amino}-3-{2-[5-chloro-1-methyl-

615





3-(trifluoromethyl)-1H-pyrazol-4-yl]-6-quinolinyl}propanoic acid


185
2S
Pure
(2S)-2-{[2-chloro-4-(methylsulfonyl)benzoyl]amino}-3-[2-(2,6-

537





dimethylphenyl)-6-quinolinyl]propanoic acid


186
**

2-{[(1-acetyl-2-pyrrolidinyl)carbonyl]amino}-3-[2-(2-methoxy-1-

512





naphthyl)-6-quinolinyl]propanoic acid


190
**

2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2-pyrrolidinyl)-6-

451





quinolinyl]propanoic acid


191
**

2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-difluorophenyl)-6-

501





quinolinyl]propanoic acid


192
**

3-[2-(2-chloro-6-nitrophenyl)-6-quinolinyl]-2-[(2,6-

544





dichlorobenzoyl)amino]propanoic acid


193
**

2-({[1-(4-chlorophenyl)cyclopentyl]carbonyl}amino)-3-[2-(2,6-

535





difluorophenyl)-6-quinolinyl]propanoic acid


194
**

3-[2-(2-chloro-6-nitrophenyl)-6-quinolinyl]-2-[(2,6-

536





dimethoxybenzoyl)amino]propanoic acid


195
**

2-[(2-chloro-6-methylbenzoyl)amino]-3-[2-(2,6-difluorophenyl)-6-

481





quinolinyl]propanoic acid


196
**

2-[(2-chloro-6-methylbenzoyl)amino]-3-[2-(2-chloro-6-nitrophenyl)-6-

524





quinolinyl]propanoic acid


197
2
Rac
3-[2-(4-chlorophenoxy)-6-quinolinyl]-2-[(2,6-

515/517/519





dichlorobenzoyl)amino]propanoic acid


198
2
Rac
3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[3,4-dioxo-2-(propylamino)-1-

498/500/502





cyclobuten-1-yl]amino}propanoic acid


199
2
Rac
methyl 2-amino-3-(2-phenyl-6-quinolinyl)propanoate

479


208
2
Rac
2-amino-3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]propanoic acid

352





hydrochloride


209
2
Rac
methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dimethoxyphenyl)-2-

538/540/542





naphthyl]propanoate


210
2
Rac
2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dimethoxyphenyl)-2-

524/526/528





naphthyl]propanoic acid


211
2
Rac
2-amino-3-[6-(2,6-dichlorophenyl)-2-naphthyl]propanoic acid

396





hydrochloride


212
2
Rac
methyl 2-amino-3-[6-(2,6-dichlorophenyl)-2-naphthyl]propanoate

410





hydrochloride


213
2
Rac
methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dichlorophenyl)-2-

548





naphthyl]propanoate


214
2
Rac
2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dichlorophenyl)-2-

532/534/536





naphthyl]propanoic acid


215
A-2§
Pure
(−)-methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dimethoxyphenyl)-2-
−34.60
538/540/542





naphthyl]propanoate
(DMSO, 1%)


216
B-2§
Pure
(+)-methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dimethoxyphenyl)-
+33.88
538/540/542





2-naphthyl]propanoate
(DMSO, 1%)


217
A-2§
Pure
(−)-2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dimethoxyphenyl)-2-
−23.95
524/526/528





naphthyl]propanoic acid
(DMSO, 1%)


218
B-2§
Pure
(+)-2-[(2,6-dichlorobenzoyl)amino]-3-[6-(2,6-dimethoxyphenyl)-2-
+26.10
524/526/528





naphthyl]propanoic acid
(DMSO, 1%)


219
2, 2S
Mixt
3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]-2-({[(2S)-1-

589





(phenylsulfonyl)pyrrolidinyl]carbonyl}amino)propanoic acid


220
2, 2S
Mixt
methyl 3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]-2-({[(2S)-1-

603





(phenylsulfonyl)pyrrolidinyl]carbonyl}amino)propanoate


221
2, 2S
Mixt
methyl 3-[6-(2,6-dimethoxyphenyl)-2-naphthyl]-2-({[(2S)-1-

477





methylpyrrolidinyl]carbonyl}amino)propanoate


222
2S
Pure
methyl (2S)-2-{[(2,4-dichloro-6-methyl-3-pyridinyl)carbonyl]amino}-3-[2-
ee: 93%
562/564/566





(2,6-dichlorophenyl)-6-quinolinyl]propanoate


223
1R, 3S, 1S
Pure
(1R,3S)-3-{[((1S)-1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-
 −3.89
557/559/561





methoxy-2-oxoethyl)amino]carbonyl}-1,2,2-
(CH3CN, 1%)





trimethylcyclopentanecarboxylic acid


224
2
Rac
2-{[(6-amino-3-pyridinyl)carbonyl]amino}-3-[2-(2,6-dichlorophenyl)-6-

481/483/485





quinolinyl]propanoic acid


225
2S
Pure
methyl (2S)-2-{[(2-amino-3-pyridinyl)carbonyl]amino}-3-[2-(2,6-
ee: 93%
495/497/499





dichlorophenyl)-6-quinolinyl]propanoate


226
2S
Pure
(2S)-2-{[(2-amino-3-pyridinyl)carbonyl]amino}-3-[2-(2,6-dichlorophenyl)-
−36.89
481/483/485





6-quinolinyl]propanoic acid
(DMSO, 1%)


227
2
Rac
2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2-methoxyphenoxy)-6-

511/513/515





quinolinyl]propanoic acid


228
2
Rac
methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dimethoxyphenyl)-6-

539/541/543





quinolinyl]propanoate


229
3S, 1R, 1S
Pure
(1R,3S)-3-[({(1S)-1-carboxy-2-[2-(2,6-dichlorophenyl)-6-
+31.54
543/545/547





quinolinyl]ethyl}amino)carbonyl]-1,2,2-trimethylcyclopentanecarboxylic
(THF, 1%)





acid


230
2S, 4R
Pure
(2S)-2-({[(4R)-3-acetyl-1,1-dioxido-1,3-thiazolidin-4-yl]carbonyl}amino)-
+34.67
550/552/554





3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid
(CH3OH, 1%)


231
2S
Pure
methyl (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[2-(1-
+37.73
562/564/566





piperidinyl)benzoyl]amino}propanoate
(CH3OH, 1%)


232
2S, 3
Mixt
methyl (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[(4-{[(1,1-

626/628/630





dioxidotetrahydro-3-thienyl)amino]methyl}benzoyl)amino]propanoate


233
2S
Pure
(2S)-2-{[(2,4-dichloro-6-methyl-3-pyidinyl)carbonyl]amino}-3-[2-(2,6-
−62.43
548/550/552/





dichlorophenyl)-6-quinolinyl]propanoic acid
(CH3OH, 1%)
554


234
2S
Pure
methyl (2S)-2-{[(2-chloro-3-pyridinyl)carbonyl]amino}-3-[2-(2,6-
+39.33
514/516/518/





dichlorophenyl)-6-quinolinyl]propanoate
(CH2Cl2, 1%)
520


235
25
Pure
(2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[2-(1-
+30.44
548/550/552





piperidinyl)benzoyl]amino}propanoic acid
(DMSO, 1%)


236
2S, 3
Mixt
(2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[(4-{[(1,1-

612/614/616





dioxidotetrahydro-3-thienyl)amino]methyl}benzoyl)amino]propanoic





acid


237
2
Rac
methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dimethoxyphenoxy)-6-

555





quinolinyl]propanoate


238
2
Rac
2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dimethoxyphenoxy)-6-

541/543





quinolinyl]propanoic acid


239
2
Rac
methyl 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenoxy)-6-

563





quinolinyl]propanoate


240
2S
Pure
(2S)-2-{[(2-chloro-3-pyridinyl)carbonyl]amino}-3-[2-(2,6-dichlorophenyl)-
−39.16
500/502/504





6-quinolinyl]propanoic acid
(CH3OH, 1%)


241
2S
Pure
methyl (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dimethoxyphenyl)-
+16.37
539/541/543





6-quinolinyl]propanoate
(CH2Cl2, 1%)


242
2R
Pure
methyl (2R)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dimethoxyphenyl)-
−17.04
539/541/543





6-quinolinyl]propanoate
(CH2Cl2, 1%)


243
2S
Pure
methyl (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dimethylphenyl)-6-
 +3.00
507/509/511





quinolinyl]propanoate
(CH2Cl2, 1%)


244
2S
Pure
(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dimethoxyphenyl)-6-
−32.15
525/527/529





quinolinyl]propanoic acid
(DMSO, 1%)


245
2R
Pure
(2R)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dimethoxyphenyl)-6-
+31.40
525/527/529





quinolinyl]propanoic acid
(DMSO, 1%)


246
2R, 2S
Pure
methyl (2R)-3-[2-(2,6-dimethoxyphenyl)-6-quinolinyl]-2-({[(2S)-2-
−29.51
479





methyltetrahydro-2-furanyl]carbonyl}amino)propanoate
(CH2Cl2, 1%)


247
2S, 2R
Pure
methyl (2S)-3-[2-(2,6-dimethoxyphenyl)-6-quinolinyl]-2-({[(2R)-2-
+31.59
479





methyltetrahydro-2-furanyl]carbonyl}amino)propanoate
(CH2Cl2, 1%)


248
2S, 2S
Pure
methyl (2S)-3-[2-(2,6-dimethoxyphenyl)-6-quinolinyl]-2-({[(2S)-2-
+32.42
479





methyltetrahydro-2-furanyl]carbonyl}amino)propanoate
(CH2Cl2, 1%)


249
2R, 2R
Pure
methyl (2R)-3-[2-(2,6-dimethoxyphenyl)-6-quinolinyl]-2-({[(2R)-2-
−33.11
479





methyltetrahydro-2-furanyl]carbonyl}amino)propanoate
(CH2Cl2, 1%)


250
2R, 2S
Pure
(2R)-3-[2-(2,6-dimethoxyphenyl)-6-quinolinyl]-2-({[(2S)-2-
−63.77
465





methyltetrahydro-2-furanyl]carbonyl}amino)propanoic acid
(CH2Cl2, 1%)


251
2S, 2R
Pure
(2S)-3-[2-(2,6-dimethoxyphenyl)-6-quinolinyl]-2-({[(2R)-2-
+65.72
465





methyltetrahydro-2-furanyl]carbonyl}amino)propanoic acid
(CH2Cl2, 1%)


252
2S, 2S
Pure
(2S)-3-[2-(2,6-dimethoxyphenyl)-6-quinolinyl]-2-({[(2S)-2-
+51.10
465





methyltetrahydro-2-furanyl]carbonyl}amino)propanoic acid
(CH2Cl2, 1%)


253
2R, 2R
Pure
(2R)-3-[2-(2,6-dimethoxyphenyl)-6-quinolinyl]-2-({[(2R)-2-
−57.31
465





methyltetrahydro-2-furanyl]carbonyl}amino)propanoic acid
(CH2Cl2, 1%)


254
2R, 4R
Pure
methyl (2R)-2-({[(4R)-3-acetyl-1,3-thiazolidin-4-yl]carbonyl}amino)-3-[2-
−20.52
524





(2,6-dimethoxyphenyl)-6-quinolinyl]propanoate
(CH2Cl2, 1%)


255
2R, 4R
Pure
(2R)-2-({[(4R)-3-acetyl-1,3-thiazolidin-4-yl]carbonyl}amino)-3-[2-(2,6-
ee: 100%
510





dimethoxyphenyl)-6-quinolinyl]propanoic acid


256
2
Rac
2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenoxy)-6-

549/551/553





quinolinyl]propanoic acid


257
2
Rac
methyl 3-[(2,6-dichlorophenyl)amino]-2-{[2-(2,6-dichlorophenyl)-6-

547/549/551





quinolinyl]methyl}-3-oxopropanoate


258
2
Rac
methyl 2-[({1-[(tert-butoxycarbonyl)amino]cyclopentyl} carbonyl)amino]-

586/588/590





3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate


259
2
Rac
methyl 2-{[(1-aminocyclopentyl)carbonyl]amino}-3-[2-(2,6-

486/488/490





dichlorophenyl)-6-quinolinyl]propanoate


260
2
Rac
2-{[(1-aminocyclopentyl)carbonyl]amino}-3-[2-(2,6-dichlorophenyl)-6-

472/474/476





quinolinyl]propanoic acid


261
1S
Pure
tert-butyl 4-(4-{[((1S)-1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-
−74  
676/678/680





methoxy-2-oxoethyl)amino]carbonyl}benzyl)-1-piperidinecarboxylate
(MeOH, 1%)


262
2S
Pure
methyl (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[4-(4-

576/578/580





piperidinylmethyl)benzoyl]amino}propanoate


263
2S
Pure
(2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[4-(4-
−20.46
562/564/566





piperidinylmethyl)benzoyl]amino}propanoic acid
(DMSO, 1%)


264
2
Rac
tert-butyl 2-[(2,6-dichlorobenzoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-

589/591/593/





quinolinyl]propanoate

595/597


265
2S
Pure
methyl (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[(4,6-dimethoxy-
 −3.93
514/516/518





1,3,5-triazin-2-yl)amino]propanoate
(CH3OH, 1%)


266
2S
Pure
(2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-{[3-(4-
 −7.93
548/550/552





piperidinyl)benzoyl]amino}propanoic acid
(DMSO, 1%)


267
2S
Pure
(2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[(4,6-dimethoxy-1,3,5-
+67.53
500/502





triazin-2-yl)amino]propanoic acid
(DMSO, 1%)


268
2S
Pure
methyl (2S)-2-{[2-(4-chlorophenyl)-2-methylpropanoyl]amino}-3-[2-(2,6-
ee: 93%
555/557/559





dichlorophenyl)-6-quinolinyl]propanoate


269
2S (95%)
Mixt
(2S)-2-{[2-(4-chlorophenyl)-2-methylpropanoyl]amino}-3-[2-(2,6-
ee: 90%
541/543/545



2R (5%)

dichlorophenyl)-6-quinolinyl]propanoic acid (95%)





(2R)-2-{[2-(4-chlorophenyl)-2-methylpropanoyl]amino}-3-[2-(2,6-





dichlorophenyl)-6-quinolinyl]propanoic acid (5%)


270
2S (95%)
Pure
(2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[(2-methyl-2-
ee: 90%
507/509/511



2R (5%)

phenylpropanoyl)amino]propanoic acid (95%)





(2R)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[(2-methyl-2-





phenylpropanoyl)amino]propanoic acid (5%)


271
2S
Pure
methyl (2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[(2-methyl-2-
ee: 94%
521/523/525





phenylpropanoyl)amino]propanoate


272
2S
Pure
(2S)-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-[({1-[2-
+26.81
556/558/560





(diethylamino)ethyl]cyclopentyl}carbonyl)amino]propanoic acid
(CH3OH, 1%)


273
2S
Pure
(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[2-(3,5-dichloro-4-pyridinyl)-6-
ee: 100%
534/536





quinolinyl]propanoic acid


274
2S, 2R
Pure
(2S)-3-[2-(3,5-dichloro-4-pyridinyl)-6-quinolinyl]-2-({[(2R)-2-
+17.58
474/476/478





methyltetrahydro-2-furanyl]carbonyl}amino)propanoic acid
(CH3OH, 1%)


275
2, 2S
Mixt
methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-({[(2S)-1-

612/614/616





(phenylsulfonyl)pyrrolidinyl]carbonyl}amino)propanoate


276
2S
Pure
methyl (2S)-2-({[1-(4-chlorophenyl)cyclopentyl]carbonyl}amino)-3-[2-
−49.28
582/584/586





(3,5-dichloro-4-pyridinyl)-6-quinolinyl]propanoate
(DMSO, 1%)


277
2S
Pure
(2S)-2-({[1-(4-chlorophenyl)cyclopentyl]carbonyl}amino)-3-[2-(3,5-
−43  
568/570/572





dichloro-4-pyridinyl)-6-quinolinyl]propanoic acid
(DMSO, 1%)


278
2S, 2S
Pure
(2S)-2-({[(2S)-1-benzyl-5-oxopyrrolidinyl]carbonyl}amino)-3-[2-(2,6-
 +5.77
562/564/566





dichlorophenyl)-6-quinolinyl]propanoic acid
(CH3OH, 1%)


279
2, 2S
Mixt
3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-({[(2S)-1-

598/600/602





(phenylsulfonyl)pyrrolidinyl]carbonyl}amino)propanoic acid


282
1
Rac
2,6-dichloro-N-{1-{[2-(2,6-dichlorophenyl)-6-quinolinyl]methyl}-2-

610/612/614





[(methylsulfonyl)amino]-2-oxoethyl}benzamide





** compounds synthesised from the corresponding “L” amino acid. The stereochemistry was not determined; the carbon atom to which R2 and R3 are attached could be in the “S” or “R” configuration, with a proportion of 2S isomer comprised between 50% and 100%.






EXAMPLE 6
In Vitro Biological Assay. U937/Vcam-1 Adhesion Assay

Compounds of the invention are tested in a VLA-4 dependent adhesion test


The VLA-4 expressing cell line U937 (ATCC n°: CRL 1593) is cultured in RPMI 1640 medium supplemented with foetal bovine serum 10%. Prior to the assay cells are washed, resuspended in HBSS BSA 0.1% at 5×106 cells/ml and loaded with the fluorescent dye Calcein-AM at a final concentration of 10 μmol/l for 15 min at 37° C. After washing, cells are resuspended in RPMI at 2×106 cells/ml. 96 well microtiter plates are coated with 50 μl aliquots of soluble human recombinant VCAM-1 (2.5 μg/ml in DPBS) overnight at 4° C. DPBS alone is added to some wells for non specific adhesion measurement. Wells are washed to remove unbound protein and blocked by incubation with 1% BSA for 1 h at 37° C. to reduce background adherence.


Compounds dissolved in DMSO are diluted in RPMI HEPES (25 mmol/l) and added to the wells in a 50 μl volume. Final DMSO concentration is 1%. Vehicle alone is added to control wells. Calcein loaded cells are then plated in 50 μl volume and the plates are incubated for 45 min at room temperature.


Fluorescence is measured using the Cytofluor plate reader (excitation: 485 nm; emission: 530 nm).


Plates are washed 4 times to remove non-adherent cells and fluorescence was read again.


The percentage of cell adhesion is calculated as: fluorescence of adherent cells/fluorescence of total cells×100 (Fx%). Nonspecific adhesion is calculated from DPBS wells (Fns%) Specific adhesion is: Fx%−Fns%.


Adhesion inhibition is calculated as the decrease of the adhesion of treated cells compared to the adhesion of control cells and expressed in percent as: 100−[(Fx%−Fns%)/(Fc%−Fns%)×100].


IC50 is evaluated from a dose-response curve using the following equation:






Y=A+((B−A)/(1+((C/XD)))


with A=minimum inhibition, B=maximum inhibition, C=IC50 and D=Hill slope.


Preferred compounds of the invention inhibit the U937 adhesion to VCAM with IC50 values below 1 μmol/l.

Claims
  • 1. A compound of formula I or a pharmaceutically acceptable salt thereof,
  • 2. The compound according to claim 1, wherein R1 is cycloalkyl, aryl, aromatic heterocycle or aralkyl;R2 is —NR4R5;R3 is —CO—R7;R4 is -G1-R8;R5 is H, or C1-4-alkyl;R7 is hydroxy, amino, hydroxylamino or an oxy derivative;G1 is CO; andR8 is aryl, heterocycle, cycloalkyl or —NH-aryl.
  • 3. The compound according to claim 2, wherein R1 is 2,6-dichlorophenyl, 2,4-dichlorophenyl, 2,6-dimethoxyphenyl, 2-nitrophenyl, 2-(trifluoromethyl)phenyl, 2-bromophenyl, 2-(1,3-benzodioxol-5-yl)-1-methylethyl, 2-methoxyphenyl, 4-(methylsulfonyl)phenyl, 5-chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl, 2,6-dimethylphenyl, 2-chloro-6-nitrophenyl, 3,5-dichloro-4-pyridinyl, 2-chloro-6-fluorophenyl, 2-methoxy-1-naphthyl, 2-mesityl;R2 is —NHR4, wherein R4 is -G1-R8;R7 is hydroxy, amino or C1-4-alkyloxy;G1 is CO; andR8 is 2,6-dichlorophenyl, 1-carboxy-1,2,2-trimethyl-3-cyclopentyl, 1-((4-methylphenyl)sulfonyl)-2-piperidinyl, 1-[(4-methylphenyl)sulfonyl]octahydro-1H-indol-2-yl, 1-(4-chlorophenyl)cyclopentyl, 2-chloro-4-(methylsulfonyl)phenyl, 2-chloro-6-methylphenyl, 3-acetyl-1,3 thiazolidin-4-yl, 2,6-dimethoxyphenyl, 2,6-dimethylphenyl, 2,6-difluorophenyl, 2-chloro-4-(methylsulfonyl)phenyl, 1-(methylsulfonyl)-2-piperidinyl, 2-methyltetrahydro-2-furanyl, 1-acetyl-2-pyrrolidinyl, 1-(phenylsulfonyl)-2-pyrrolidinyl, 2,4-dichloro-6-methyl-3-pyridinyl, 1-benzyl-5-oxo-2-pyrrolidinyl, 3-acetyl-1,1-dioxido-1,3-thiazolidin-4-yl or 1-[2-(diethylamino)ethyl]cyclopentyl.
  • 4. The compound according to claim 3, wherein R1 is 2,6-dichlorophenyl, 2,6-dimethoxyphenyl, 3,5-dichloro-4-pyridinyl, 2-nitrophenyl, 2-chloro-6-fluorophenyl, 2-methoxy-1-naphthyl or 2-chloro-6-nitrophenyl;R2 is —NH—C(═O)R8;R7 is hydroxy or C1-4-alkyloxy; andR8 is 2,6-dichlorophenyl, 1-carboxy-1,2,2-trimethyl-3-cyclopentyl, 1-((4 methylphenyl)sulfonyl)-2-piperidinyl, 1-[(4-methylphenyl)sulfonyl]octahydro-1H-indol-2-yl, 1-(4-chlorophenyl)cyclopentyl, 2-chloro-4-(methylsulfonyl)phenyl, 2-chloro-6-methylphenyl, 1-(phenylsulfonyl)-2-pyrrolidinyl, 2,4-dichloro-6-methyl-3-pyridinyl or 1-benzyl-5-oxo-2-pyrrolidinyl.
  • 5. The compound according to claim 1, wherein, when the carbon atom to which R2 and R3 are attached is asymmetric, it is in the “S”-configuration.
  • 6. The compound according to claim 1 selected from the group consisting of:
  • 7. A compound selected from the group consisting of:
  • 8. A composition comprising as active ingredient a therapeutically effective amount of a compound according to claim 1 and a pharmaceutically acceptable adjuvant, diluent or carrier.
  • 9-12. (canceled)
  • 13. A compound of formula II,
  • 14. A compound of formula III,
  • 15. A compound of formula IV,
  • 16. A compound of formula VI,
  • 17. A compound selected from the group consisting of:
  • 18. A composition comprising as active ingredient a therapeutically effective amount of a compound according to claim 7 and a pharmaceutically acceptable adjuvant, diluent or carrier.
  • 19. A method for the treatment of a VLA-4 dependent inflammatory disease, comprising the step of administering a therapeutically effective amount of a compound according to claim 1 to a patient in need thereof.
  • 20. A method for the treatment of a VLA-4 dependent inflammatory disease, comprising the step of administering a therapeutically effective amount of a compound according to claim 7 to a patient in need thereof.
  • 21. A method for the treatment of asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, inflammatory skin disorders, autoimmune disorders, or atherosclerosis, comprising the step of administering a therapeutically effective amount of a compound according to claim 1 to a patient in need thereof.
  • 22. The method according to claim 21, wherein the treatment is for an inflammatory skin disorder selected from dermatitis, psoriasis, urticaria, pruritus, and eczema.
  • 23. The method according to claim 21, wherein the treatment is for an autoimmune disorder selected from rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
  • 24. The method according to claim 23, wherein the treatment is for an inflammatory bowel disease selected from Crohn's disease and ulcerative colitis.
  • 25. A method for the treatment of asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, inflammatory skin disorders, autoimmune disorders, or atherosclerosis, comprising the step of administering a therapeutically effective amount of a compound according to claim 7 to a patient in need thereof.
  • 26. The method according to claim 25, wherein the treatment is for an inflammatory skin disorder selected from dermatitis, psoriasis, urticaria, pruritus, and eczema.
  • 27. The method according to claim 25, wherein the treatment is for an autoimmune disorder selected from rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
  • 28. The method according to claim 26, wherein the treatment is for an inflammatory bowel disease selected from Crohn's disease and ulcerative colitis.
Priority Claims (1)
Number Date Country Kind
02009746.5 Apr 2002 EP regional
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/EP03/03909 4/15/2003 WO 00 11/21/2005